Details of Disease

General Information of Disease (ID: DISVY326)

Disease Name B-cell neoplasm
Synonyms lymphoma, B-cell; B-cell lymphoma; B-cell neoplasm; B-cell lymphocytic neoplasm
Definition A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
Disease Hierarchy
DIS17G9I: Leukocyte disorder
DISN6V4S: Lymphoma
DIS9S8BC: Lymphoid neoplasm
DISVY326: B-cell neoplasm
Disease Identifiers
MONDO ID
MONDO_0004095
MESH ID
D016393
UMLS CUI
C0079731
MedGen ID
86953
HPO ID
HP:0012191
SNOMED CT ID
109979007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 3 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Bortezomib DMNO38U Approved Small molecular drug [1]
Dexamethasone DMMWZET Approved Small molecular drug [2]
Rituximab DM1YVZT Approved Antibody [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 284 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCC1 TTOI92F Limited Altered Expression [4]
ABCC2 TTFLHJV Limited Altered Expression [5]
AICDA TTKRTP6 Limited Biomarker [6]
AKT3 TTO6SGY Limited Altered Expression [7]
ALK TTPMQSO Limited Altered Expression [8]
ATM TTKBM7V Limited Altered Expression [9]
ATR TT8ZYBQ Limited Altered Expression [9]
BECN1 TT5M7LN Limited Biomarker [10]
BIRC3 TTAIWZN Limited Altered Expression [11]
BTK TTGM6VW Limited Biomarker [12]
CASR TTBUYHA Limited Biomarker [13]
CBX7 TTBN3HC Limited Biomarker [14]
CCL3 TT8I4WB Limited Altered Expression [15]
CCNB1 TT9P6OW Limited Altered Expression [16]
CD22 TTM6QSK Limited Biomarker [17]
CD274 TT8ZLTI Limited Altered Expression [18]
CD40 TT1ERKL Limited Biomarker [19]
CD70 TTNCIE0 Limited Biomarker [20]
CD79B TTBN5I7 Limited Biomarker [13]
EP300 TTGH73N Limited Genetic Variation [21]
ERN1 TTKIAT3 Limited Altered Expression [22]
FCGR2A TTXT21W Limited Genetic Variation [23]
FCGR3A TTIFOC0 Limited Biomarker [24]
FOSL2 TT689IR Limited Altered Expression [25]
HDAC3 TT4YWTO Limited Biomarker [18]
IL15 TTJFA35 Limited Altered Expression [26]
IL23A TTC1GLB Limited Altered Expression [27]
IL25 TTVMO5W Limited Altered Expression [28]
INPP5D TTTP2Z1 Limited Biomarker [29]
ITGAE TTH0Z37 Limited Biomarker [30]
JAK1 TT6DM01 Limited Biomarker [31]
JAK2 TTRMX3V Limited Posttranslational Modification [32]
KHDRBS1 TTAT6C7 Limited Biomarker [33]
KIR3DL2 TTQH3N0 Limited Altered Expression [34]
LMO2 TTFX379 Limited Biomarker [35]
MAP3K19 TTRHJA3 Limited Biomarker [36]
MCL1 TTL53M6 Limited Biomarker [37]
MDM4 TT9OUDQ Limited Altered Expression [4]
MGMT TTJ8DV7 Limited Altered Expression [38]
MKI67 TTB4UNG Limited Biomarker [39]
MMP13 TTHY57M Limited Biomarker [40]
MYD88 TTB6Q2O Limited Biomarker [41]
NR0B2 TT25A9Q Limited Biomarker [42]
NR1I3 TTRANFM Limited Biomarker [13]
NR4A1 TTMXE2Q Limited Biomarker [43]
PDE4A TTZ97H5 Limited Biomarker [44]
PGR TTUV8G9 Limited Altered Expression [45]
PIK3CB TT9H4P3 Limited Altered Expression [46]
PIM1 TTTN5QW Limited Biomarker [47]
PRKAR1A TTNAHEX Limited Biomarker [13]
PRMT5 TTR1D7X Limited Altered Expression [48]
PTK2B TTTEFBV Limited Altered Expression [46]
PTPN6 TT369M5 Limited Biomarker [42]
SERPINC1 TT4QPUL Limited Altered Expression [49]
SLC22A1 TTM5Q4V Limited Biomarker [50]
SPN TTOZAX0 Limited Altered Expression [30]
SYK TT2HUPM Limited Biomarker [51]
TNFAIP3 TT5W0IO Limited Biomarker [52]
TNFSF13 TTOI1RM Limited Biomarker [53]
TRAF6 TTCDR6M Limited Biomarker [28]
TRPV2 TTBECWA Limited Altered Expression [54]
UCP2 TTSC2YM Limited Altered Expression [55]
WNK1 TTJ9UMX Limited Altered Expression [56]
WNT5A TTKG7F8 Limited Altered Expression [57]
WWP2 TT6TU05 Limited Altered Expression [58]
XIAP TTK3WBU Limited Genetic Variation [59]
IL31 TT1RJXK Disputed Biomarker [60]
CR2 TT0HUN7 moderate Altered Expression [61]
CSF3 TT5TQ2W moderate Biomarker [62]
FASLG TTO7014 moderate Altered Expression [63]
GBA TT1B5PU moderate Biomarker [64]
IFNGR2 TT13TL0 moderate Genetic Variation [65]
MTR TTUTO39 moderate Genetic Variation [66]
NPR2 TTNB7IF moderate Biomarker [64]
PDX1 TT8SGZK moderate Biomarker [67]
PIM2 TT69J2Z moderate Biomarker [68]
SOX5 TTXHSZK moderate Biomarker [69]
TK1 TTP3QRF moderate Altered Expression [70]
TRPM8 TTXDKTO moderate Altered Expression [71]
ABCC4 TTUEAFL Strong Altered Expression [72]
ABL2 TT1A6HL Strong Altered Expression [73]
ACACB TTY84UG Strong Biomarker [74]
ADCYAP1R1 TT5OREU Strong Biomarker [75]
AIMP2 TTXWHGF Strong Posttranslational Modification [76]
ANXA5 TT2Z83I Strong Altered Expression [77]
APCS TTB7VAT Strong Biomarker [78]
ARG1 TT7ZQEV Strong Genetic Variation [79]
ATP2A2 TTE6THL Strong Altered Expression [80]
BACH1 TT2ME4S Strong Biomarker [81]
BBC3 TT7JUKC Strong Biomarker [82]
BCL11A TTR61MW Strong Biomarker [83]
BCL2A1 TTGT9C7 Strong Biomarker [84]
BIRC2 TTQ5LRD Strong Altered Expression [85]
BMP6 TT07RIB Strong Altered Expression [86]
BRD1 TTT09OB Strong Altered Expression [87]
BTG1 TTL7N2W Strong Biomarker [88]
BTLA TTER58P Strong Genetic Variation [89]
CA9 TT2LVK8 Strong Biomarker [90]
CASP4 TT6KIOT Strong Biomarker [91]
CASP7 TTM7Y45 Strong Biomarker [92]
CBLB TTHRAIJ Strong Biomarker [93]
CCKBR TTVFO0U Strong Biomarker [94]
CCND1 TTFCJ7S Strong Altered Expression [95]
CCND3 TT1JXNR Strong Genetic Variation [96]
CD14 TT6I7DC Strong Biomarker [97]
CD200 TT0BE68 Strong Biomarker [98]
CD27 TTDO1MV Strong Altered Expression [99]
CD28 TTQ13FT Strong Biomarker [100]
CD37 TTFCW29 Strong Altered Expression [101]
CD38 TTPURFN Strong Altered Expression [102]
CD40LG TTIJP3Q Strong Biomarker [103]
CD5 TTEGYK1 Strong Altered Expression [104]
CD52 TTQT5S9 Strong Altered Expression [105]
CDC25A TTLZS4Q Strong Altered Expression [106]
CDK1 TTH6V3D Strong Biomarker [107]
CDK6 TTO0FDJ Strong Biomarker [108]
CNTN2 TT2Z1WB Strong Biomarker [109]
COPS5 TTSTNJR Strong Biomarker [110]
CRK TTFEUYR Strong Posttranslational Modification [76]
CS TTZA6B3 Strong Altered Expression [111]
CSPG4 TT7MYXI Strong Biomarker [112]
CTSC TT4H0V2 Strong Altered Expression [113]
CXCL13 TT0NIZ1 Strong Altered Expression [114]
CXCR5 TTIW59R Strong Altered Expression [115]
DFFA TTYVQ9C Strong Biomarker [116]
DFFB TT2SRE0 Strong Biomarker [116]
E2F3 TTWIJYH Strong Biomarker [117]
EPHA5 TTV9KOD Strong Biomarker [118]
EPHA7 TTAHTVG Strong Altered Expression [119]
EZH2 TT9MZCQ Strong Biomarker [120]
F7 TTF0EGX Strong Altered Expression [121]
FAS TT7LTUJ Strong Altered Expression [122]
FBXO11 TT6G10V Strong Biomarker [123]
FCGR2B TT5RWKQ Strong Altered Expression [124]
FGR TTPOGS1 Strong Biomarker [125]
FOXP1 TT0MUCI Strong Biomarker [126]
GFAP TTI6FFX Strong Altered Expression [127]
GRIA2 TTWM461 Strong Altered Expression [128]
GRIK2 TT0K5RG Strong Genetic Variation [129]
GSS TTVEWR4 Strong Altered Expression [130]
GSTO1 TTWO3SH Strong Altered Expression [131]
HGFAC TTD96RW Strong Altered Expression [132]
HK2 TTK02H8 Strong Altered Expression [133]
HSP90AA1 TT78R5H Strong Biomarker [134]
HSPA12B TTAI9ZQ Strong Posttranslational Modification [135]
HSPA5 TTW26OG Strong Biomarker [136]
IKZF2 TTKT5NV Strong Genetic Variation [137]
IL10RB TTJTRMK Strong Genetic Variation [138]
IL11RA TTZPLJS Strong Biomarker [139]
IL12A TTRTK6Y Strong Biomarker [140]
IL2 TTF89GD Strong Biomarker [141]
IL21 TT9QEJ6 Strong Biomarker [142]
IL22 TTLDX4N Strong Biomarker [142]
IL24 TT1EPXZ Strong Altered Expression [143]
IL3RA TTENHJ0 Strong Altered Expression [144]
IL4 TTLGTKB Strong Altered Expression [145]
IL5 TTPREZD Strong Genetic Variation [65]
IL7 TT8FRMO Strong Altered Expression [146]
IRS2 TTF95B8 Strong Altered Expression [147]
ITGA4 TTJMF9P Strong Biomarker [148]
ITPR1 TT5HWAT Strong Biomarker [149]
ITPR3 TTH1769 Strong Biomarker [149]
JAK3 TTT7PJU Strong Altered Expression [150]
KAT6B TTH4VJL Strong Altered Expression [151]
KDM3A TTKXS4A Strong Biomarker [152]
KLF4 TTTI53X Strong Altered Expression [153]
LAIR1 TTSI7A8 Strong Biomarker [154]
LAMP1 TTC214J Strong Genetic Variation [155]
LGALS1 TTO3NYT Strong Biomarker [156]
LHCGR TT2O4W9 Strong Altered Expression [157]
LONP1 TTM1VPZ Strong Altered Expression [158]
MALT1 TTCI81G Strong Biomarker [159]
MAP3K1 TTW8TJI Strong Biomarker [160]
MAP3K20 TTTUZ3O Strong Genetic Variation [161]
MAP3K7 TTJQT60 Strong Altered Expression [162]
MAP4 TT0VFPN Strong Genetic Variation [163]
MAP4K3 TTI0AHJ Strong Altered Expression [164]
MAPK7 TTU6FSC Strong Altered Expression [165]
MAPK8 TT0K6EO Strong Biomarker [166]
MAPK9 TT3IVG2 Strong Altered Expression [167]
MDM2 TT9TE0O Strong Altered Expression [168]
MELK TTBZOTY Strong Biomarker [169]
METAP2 TTZL0OI Strong Altered Expression [170]
MTA1 TTO4HUS Strong Biomarker [171]
NACC1 TT4AQ5F Strong Genetic Variation [172]
NCF1 TTZ4JC3 Strong Altered Expression [173]
NEK2 TT3VZ24 Strong Biomarker [174]
NEK6 TT8I2M7 Strong Altered Expression [175]
NES TTHZ752 Strong Altered Expression [176]
NFKB2 TTKLNRV Strong Genetic Variation [177]
NPM1 TTHBS98 Strong Biomarker [178]
NR4A3 TTJQB49 Strong Biomarker [43]
NRAS TTW2R9X Strong Biomarker [179]
NTF3 TTZHKV9 Strong Genetic Variation [180]
OXSR1 TT7ZY03 Strong Altered Expression [181]
PCNA TTLG1PD Strong Altered Expression [182]
PDCD1 TTNBFWK Strong Biomarker [18]
PDE4B TTVIAT9 Strong Biomarker [44]
PIKFYVE TTA4M1N Strong Biomarker [183]
PIM3 TTCGOIN Strong Altered Expression [184]
PKM TT4LOT8 Strong Altered Expression [77]
PLK1 TTH4IP0 Strong Biomarker [185]
PLK2 TT976FS Strong Biomarker [186]
PMS1 TTX1ISF Strong Genetic Variation [160]
PREP TTNGKET Strong Biomarker [187]
PRKCE TT57MT2 Strong Posttranslational Modification [188]
PTGS2 TTVKILB Strong Altered Expression [189]
PTPN1 TTELIN2 Strong Biomarker [190]
PTPRJ TTWMKXP Strong Altered Expression [191]
RARG TT1Q3IE Strong Biomarker [192]
REL TT1ZCTH Strong Biomarker [193]
RIPK1 TTVJHX8 Strong Genetic Variation [194]
RIPK2 TTCQ2E5 Strong Biomarker [195]
RIPK4 TTB4S01 Strong Biomarker [196]
ROCK2 TTGWKQJ Strong Altered Expression [197]
RSF1 TTMP86V Strong Biomarker [11]
SCAP TTL6U2P Strong Biomarker [198]
SDC1 TTYDSVG Strong Altered Expression [199]
SEPTIN6 TTAGE7U Strong Biomarker [200]
SGCB TTEDCQ0 Strong Altered Expression [201]
SLC2A4 TTP6MT5 Strong Biomarker [202]
SLC8A1 TTCF82X Strong Biomarker [81]
SMAD1 TT9GR53 Strong Posttranslational Modification [203]
SOCS1 TT8COJM Strong Genetic Variation [204]
SQSTM1 TTOT2RY Strong Biomarker [205]
STK38 TT27XFN Strong Altered Expression [206]
STK39 TTYQTIU Strong Posttranslational Modification [207]
TCF3 TTULOD8 Strong Biomarker [208]
TCL1A TTUKRDV Strong Altered Expression [209]
TIGIT TTWNL74 Strong Biomarker [210]
TLR9 TTSHG0T Strong Biomarker [140]
TMBIM6 TT7QSMG Strong Altered Expression [211]
TNFRSF10A TT5WLRX Strong Altered Expression [212]
TNFRSF10B TTW20TU Strong Altered Expression [213]
TNFRSF13C TT7NJSE Strong Biomarker [214]
TNFRSF14 TTWGTC1 Strong Genetic Variation [89]
TNFRSF17 TTZ3P4W Strong Biomarker [215]
TNFRSF4 TTL31H0 Strong Altered Expression [216]
TNFRSF9 TTPW9LJ Strong Biomarker [100]
TNFSF13B TTWMIDN Strong Biomarker [217]
TNFSF14 TTKVENM Strong Biomarker [218]
TPCN1 TTODQE2 Strong Altered Expression [219]
TRIM28 TTQ2BKV Strong Biomarker [220]
TRPM4 TTJ2HKA Strong Biomarker [221]
TSLP TTHMW3T Strong Altered Expression [222]
TXNRD1 TTR7UJ3 Strong Altered Expression [223]
UCP1 TTI12YJ Strong Biomarker [202]
USP44 TTJLTNM Strong Biomarker [224]
VDAC1 TTAMKGB Strong Biomarker [225]
WNT7A TT8NARC Strong Altered Expression [57]
XPO1 TTCJUR4 Strong Biomarker [226]
XRCC5 TTCB9KW Strong Altered Expression [227]
YES1 TT0SQ8J Strong Biomarker [228]
AMACR TTLN1AP Definitive Altered Expression [229]
CCL17 TTMPHAE Definitive Altered Expression [230]
CD33 TTJVYO3 Definitive Genetic Variation [231]
CEL TTTRNQW Definitive Biomarker [232]
CHUK TT1F8OQ Definitive Biomarker [233]
CR1 TTEA8OW Definitive Genetic Variation [231]
DUSP5 TTZN92A Definitive Genetic Variation [234]
EPHA1 TTLFZVU Definitive Genetic Variation [231]
FCGRT TTKLPHO Definitive Biomarker [235]
GSK3A TTQWAU1 Definitive Biomarker [236]
HAL TTXQOZW Definitive Genetic Variation [237]
ID2 TTW8A5N Definitive Altered Expression [238]
IL15RA TTGN89I Definitive Posttranslational Modification [239]
ITGAL TT48WR6 Definitive Altered Expression [61]
LYN TT1RWNJ Definitive Altered Expression [240]
MANF TT56RYE Definitive Altered Expression [241]
MAP3K14 TT4LIAC Definitive Altered Expression [242]
MCM7 TT1RM3F Definitive Altered Expression [243]
PBK TTMY6BZ Definitive Altered Expression [242]
PDCD2 TTYOVWN Definitive Altered Expression [244]
PSMD10 TT2H4LN Definitive Altered Expression [131]
PTPN7 TT2C1DT Definitive Altered Expression [245]
RPE65 TTBOH16 Definitive Altered Expression [246]
SLC22A2 TT0XOJN Definitive Biomarker [247]
STAT6 TTWOE1T Definitive Altered Expression [145]
TBL1XR1 TTYXT16 Definitive Biomarker [248]
TRB TT84HCW Definitive Genetic Variation [249]
TRBC1 TT1DHW2 Definitive Genetic Variation [249]
VDAC2 TTM1I7L Definitive Altered Expression [250]
VEGFD TTOM5H4 Definitive Altered Expression [251]
VTCN1 TTCK85E Definitive Biomarker [252]
------------------------------------------------------------------------------------
⏷ Show the Full List of 284 DTT(s)
This Disease Is Related to 9 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC2A2 DTUJPOL moderate Biomarker [67]
SLC25A16 DTNU9EW Strong Biomarker [253]
SLC28A3 DT4YL5R Strong Altered Expression [5]
SLC35B2 DT81RKJ Strong Biomarker [144]
SLC39A5 DTN9ACR Strong Altered Expression [254]
SLC4A2 DTF7GAL Strong Biomarker [255]
ABCA7 DTDVSJA Definitive Genetic Variation [231]
SLC25A3 DTCRIWV Definitive Genetic Variation [190]
SLC27A5 DT0TQS3 Definitive Biomarker [232]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DTP(s)
This Disease Is Related to 8 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AK2 DEY1FJO Strong Biomarker [256]
CES2 DETHCPD Strong Biomarker [257]
EGLN3 DEMQTKH Strong Biomarker [258]
GLDC DEIN8FB Strong Altered Expression [259]
GSTA4 DEH7XYP Strong Altered Expression [260]
P4HA2 DE5EGK0 Strong Biomarker [261]
ASNS DEXISVQ Definitive Altered Expression [262]
UBASH3B DE10BJ5 Definitive Biomarker [236]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DME(s)
This Disease Is Related to 401 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ARHGAP24 OTCQCEZS Limited Biomarker [263]
ARR3 OTRZ00CH Limited Biomarker [13]
BAG1 OTRQNIA4 Limited Biomarker [264]
BAG3 OTVXYUDQ Limited Biomarker [265]
BCL2L12 OTS6IFZY Limited Altered Expression [266]
BIK OTTH1T3D Limited Biomarker [267]
CD99 OTPUZ5DE Limited Altered Expression [268]
CFHR3 OTYL8SDO Limited Altered Expression [269]
CIB1 OT4BVCRU Limited Biomarker [270]
CIITA OTRJNZFO Limited Genetic Variation [271]
CLEC4D OTT7X1UC Limited Biomarker [272]
CXADR OT9ZP02A Limited Biomarker [13]
CYLD OT37FKH0 Limited Altered Expression [273]
DCTN4 OTM7C943 Limited Biomarker [33]
DDIT3 OTI8YKKE Limited Genetic Variation [274]
DDX56 OTGURA53 Limited Biomarker [275]
DNM1L OTXK1Q1G Limited Altered Expression [276]
ERCC1 OTNPYQHI Limited Altered Expression [277]
ESM1 OT331Y8V Limited Altered Expression [278]
FCRL5 OTA7VHNE Limited Altered Expression [279]
FH OTEQWU6Q Limited Biomarker [272]
GCSAM OTZNOPYK Limited Altered Expression [280]
GNB3 OTA6HYBA Limited Genetic Variation [281]
GORASP1 OTQS91S7 Limited Altered Expression [56]
GTF2H1 OTCRXC6B Limited Biomarker [33]
HCCS OTQE88BE Limited Biomarker [282]
HYAL2 OTTVINXW Limited Altered Expression [283]
ICAM3 OTTZ5A5D Limited Altered Expression [284]
IL10RA OTOX3D1D Limited Genetic Variation [138]
KLHL6 OTLDECOX Limited Biomarker [285]
KMT2D OTTVHCLY Limited Altered Expression [286]
LITAF OTT5JX1F Limited Biomarker [287]
MIB1 OT5C404P Limited Genetic Variation [288]
MSH3 OTD3YPVL Limited Altered Expression [4]
NOP53 OTA2YKO6 Limited Biomarker [289]
NOVA1 OT6A9KHY Limited Altered Expression [290]
NUP62 OTMN63DH Limited Biomarker [33]
NUS1 OT4DQ82L Limited Genetic Variation [291]
PCDH10 OT2GIT0E Limited Posttranslational Modification [292]
PMAIP1 OTXEE550 Limited Altered Expression [293]
POU2F1 OTK7ELJ0 Limited Biomarker [50]
PPP1R15A OTYG179K Limited Biomarker [294]
RMDN1 OTE1NB6U Limited Altered Expression [295]
RMDN2 OTK5WSFI Limited Altered Expression [295]
RMDN3 OTKO7AUM Limited Altered Expression [295]
RTEL1 OTI3PJCT Limited Biomarker [296]
RTL1 OTOT33IM Limited Altered Expression [297]
SASH1 OTQA8BD4 Limited Altered Expression [298]
SPG7 OT8OY9ST Limited Biomarker [13]
SYBU OT3FQV7N Limited Altered Expression [295]
SYT1 OTVTPOI6 Limited Altered Expression [56]
TBC1D9 OTSSCTB5 Limited Altered Expression [299]
TP73 OT0LUO47 Limited Biomarker [263]
TRIM11 OTMD6IM2 Limited Altered Expression [300]
TRIM13 OTQIUACB Limited Biomarker [13]
PCDHGA3 OTTOGYJA Disputed Altered Expression [301]
AP5M1 OTDLWEBL moderate Altered Expression [302]
ATG12 OTJRO09Y moderate Biomarker [303]
BATF3 OTI61WXQ moderate Biomarker [304]
CLDN1 OT27KV99 moderate Altered Expression [305]
CNBP OTTGM9NK moderate Altered Expression [67]
EEF2 OTZ7SZ39 moderate Biomarker [306]
FMOD OT9EJ5H8 moderate Genetic Variation [307]
GABPA OT9YB2SA moderate Biomarker [308]
HOXC5 OTPQTLKZ moderate Altered Expression [309]
HOXC6 OTBCRAZV moderate Altered Expression [309]
HUWE1 OTFH6BJS moderate Biomarker [310]
LYPD5 OTGP7UKA moderate Altered Expression [171]
MYCT1 OTZ8A9L3 moderate Altered Expression [311]
NUPR1 OT4FU8C0 moderate Altered Expression [312]
PDHX OTG7O271 moderate Biomarker [67]
PRMT6 OT5V3XIN moderate Altered Expression [313]
RNF182 OT08FLHZ moderate Biomarker [306]
SIGLEC10 OTD1WDQL moderate Biomarker [314]
TNFRSF6B OTKAN9G7 moderate Altered Expression [315]
ACSF3 OT3WZW8S Strong Genetic Variation [316]
AHI1 OT8K2YWY Strong Genetic Variation [317]
AHSA1 OTC7AFHT Strong Posttranslational Modification [76]
AIRE OTA7G1Y1 Strong Altered Expression [318]
AMBRA1 OTY0YGT9 Strong Biomarker [319]
AMFR OTQRX7LC Strong Altered Expression [320]
ANP32B OT3SQMLU Strong Biomarker [53]
APAF1 OTJWIVY0 Strong Altered Expression [321]
AQP5 OT77GBY8 Strong Biomarker [322]
ARHGEF7 OT9BPJCL Strong Biomarker [19]
ASCC1 OTH4VAP9 Strong Biomarker [19]
ASCL2 OT3D62WB Strong Altered Expression [323]
ATF6 OTAFHAVI Strong Biomarker [324]
ATF6B OTT2ZGSR Strong Altered Expression [325]
ATMIN OTEADE76 Strong Biomarker [326]
ATP2A1 OT959A3A Strong Biomarker [327]
ATP5F1A OT3FZDLX Strong Altered Expression [327]
ATP5MC1 OTOLSYOI Strong Altered Expression [327]
ATP5MC2 OTA5F480 Strong Altered Expression [327]
ATP5PF OTDAE8FP Strong Altered Expression [327]
AUTS2 OTAEXHSC Strong Biomarker [328]
BACH2 OT17GS18 Strong Biomarker [329]
BAG2 OTI6LD27 Strong Genetic Variation [330]
BCL11B OT8KKCVJ Strong Biomarker [331]
BCL2L10 OTYXQJ3I Strong Altered Expression [332]
BCL2L11 OTNQQWFJ Strong Genetic Variation [333]
BCL3 OT1M5B95 Strong Genetic Variation [334]
BCL9 OTRBIPR4 Strong Genetic Variation [335]
BCOR OTG013AX Strong Biomarker [336]
BEX1 OTBQIF0H Strong Altered Expression [337]
BID OTOSHSHU Strong Biomarker [338]
BIRC6 OTCQJAB0 Strong Altered Expression [339]
BMF OT90NSLI Strong Genetic Variation [340]
BOK OTDQPDIX Strong Biomarker [341]
C17orf99 OTC9D6WB Strong Altered Expression [342]
CABIN1 OT4G5CIK Strong Biomarker [343]
CADM1 OTRWG9QS Strong Altered Expression [344]
CAPG OTJ86KI6 Strong Altered Expression [345]
CARD10 OT2RPM4I Strong Genetic Variation [346]
CARD11 OTRCTLYC Strong Genetic Variation [347]
CARD9 OTJ81AWD Strong Altered Expression [348]
CAVIN4 OTB1DM2C Strong Altered Expression [349]
CBFA2T3 OTOJ10S1 Strong Genetic Variation [316]
CCL4 OT6B8P25 Strong Altered Expression [350]
CCNH OTKDU3SR Strong Altered Expression [351]
CD81 OTQFXNAZ Strong Biomarker [352]
CDS1 OT2F591M Strong Genetic Variation [353]
CHI3L1 OT2Z7VJH Strong Genetic Variation [354]
CHSY1 OTB1XSSF Strong Altered Expression [355]
CILK1 OTWOYEYP Strong Altered Expression [242]
CLDN5 OTUX60YO Strong Altered Expression [56]
CLEC10A OTD8HQT6 Strong Biomarker [356]
CLEC2D OTVRLKPM Strong Altered Expression [357]
CLIC4 OT6KTPKD Strong Biomarker [358]
CLTC OTBFASMA Strong Biomarker [359]
COL11A2 OT3BQUBH Strong Altered Expression [350]
CPEB4 OTW1SCZW Strong Altered Expression [360]
CPQ OTTNZNLD Strong Genetic Variation [361]
CTBP1 OTVYH2DH Strong Altered Expression [362]
CTHRC1 OTV88X2G Strong Altered Expression [363]
CYBA OT16N9ZO Strong Biomarker [364]
DCLRE1C OTW3KB1I Strong Biomarker [365]
DCTN6 OTI8PIN9 Strong Altered Expression [344]
DDX6 OTKWXVDY Strong Biomarker [275]
DNAI2 OTHK0PS4 Strong Biomarker [366]
DNAJB7 OT4BOECZ Strong Altered Expression [367]
DOCK2 OTZTS3PA Strong Biomarker [368]
DSPP OT1TYNDN Strong Altered Expression [176]
DUOX1 OTQ2AEW0 Strong Altered Expression [369]
DUOX2 OTU14HCN Strong Altered Expression [369]
DUSP2 OTH54FMR Strong Biomarker [75]
DUSP4 OT6WAO12 Strong Altered Expression [370]
DYNLL1 OTR69LHT Strong Biomarker [326]
EAF2 OTSOET5L Strong Biomarker [371]
EBF1 OTZ61YYH Strong Altered Expression [165]
EIF4A1 OTMTBX6N Strong Biomarker [372]
EIF4A2 OT08H03R Strong Biomarker [372]
ENDOG OT5IM7B3 Strong Biomarker [373]
ERVFRD-1 OT3064D7 Strong Altered Expression [374]
ESPL1 OTMGEVOK Strong Biomarker [375]
FAIM2 OT6QINVO Strong Altered Expression [376]
FBLIM1 OTFHXMON Strong Altered Expression [377]
FBP1 OTQBANEP Strong Altered Expression [378]
FCER1A OTIRUOHF Strong Altered Expression [202]
FCRL4 OT3DVTRV Strong Biomarker [379]
FCRLA OT6MK4M1 Strong Altered Expression [380]
FKBP14 OT55W5WC Strong Altered Expression [381]
FOXO4 OT90X9LN Strong Altered Expression [382]
FXYD5 OT81DIOD Strong Biomarker [383]
GAB2 OTBFN705 Strong Biomarker [384]
GBE1 OTK2N05B Strong Genetic Variation [385]
GDE1 OTU6FSBF Strong Altered Expression [386]
GFRA1 OT3WBVYB Strong Altered Expression [387]
GLIS2 OTOUUV1X Strong Biomarker [388]
GOPC OTRBGH71 Strong Altered Expression [377]
GPX4 OTRAFFX2 Strong Biomarker [389]
GRAP2 OTS5NIZ3 Strong Posttranslational Modification [76]
GSPT2 OTN0K7F3 Strong Altered Expression [390]
GUK1 OTLI0HRU Strong Biomarker [391]
H4C1 OTB71W46 Strong Genetic Variation [392]
HACE1 OTEZULKD Strong Biomarker [393]
HBG1 OTVL4NSU Strong Altered Expression [394]
HBG2 OT4J48JJ Strong Altered Expression [394]
HELLS OTVVV668 Strong Biomarker [395]
HIP1 OT7AKCFQ Strong Biomarker [396]
HNRNPD OT5UO1FA Strong Biomarker [397]
HNRNPK OTNPRM8U Strong Biomarker [398]
HNRNPL OT0DJX74 Strong Biomarker [399]
HOXA6 OTHJP8M2 Strong Biomarker [400]
HPR OTXSC9UB Strong Altered Expression [401]
HSPA14 OTZCA5LK Strong Altered Expression [130]
HSPH1 OTVRR73T Strong Altered Expression [402]
HTRA2 OTC7616F Strong Biomarker [403]
HYPK OTRWRVWN Strong Biomarker [256]
IBTK OTB2GM4G Strong Biomarker [404]
ID3 OTUULW5Z Strong Altered Expression [405]
IFI27 OTI2XGIT Strong Altered Expression [344]
IGF2BP1 OT9G360P Strong Altered Expression [406]
IL1RAPL1 OTW3T4B2 Strong Biomarker [407]
IL4I1 OTK54C63 Strong Biomarker [408]
ILF2 OTWWVM9X Strong Altered Expression [341]
IQGAP3 OT4RZV2M Strong Altered Expression [409]
ISCU OTSW6DQP Strong Biomarker [356]
ITM2B OTMXEPXB Strong Altered Expression [410]
ITPKB OTSVVPAV Strong Genetic Variation [411]
JCHAIN OTR8M5TX Strong Biomarker [247]
JUNB OTG2JXV5 Strong Altered Expression [412]
KDSR OTCIES3H Strong Altered Expression [413]
KIF14 OTXHT4JM Strong Biomarker [414]
KLF2 OTIP1UFX Strong Altered Expression [415]
KMT2B OTMMAZQX Strong Genetic Variation [416]
LEF1 OTWS5I5H Strong Biomarker [417]
LIG4 OT40DNXU Strong Genetic Variation [418]
LIN9 OTLHW00C Strong Biomarker [419]
LRG1 OTLD0KWA Strong Altered Expression [420]
LRIG1 OTY5HZN5 Strong Altered Expression [421]
LRP12 OTRT1UJ7 Strong Posttranslational Modification [64]
LY6G6D OTG75QOC Strong Biomarker [422]
MAD2L1 OTXNGZCG Strong Biomarker [423]
MAGED1 OT6EOLFC Strong Biomarker [328]
MAP1LC3B OTUYHB84 Strong Altered Expression [424]
MAP6 OTPUI00F Strong Genetic Variation [425]
MARCHF8 OTH7PNN2 Strong Genetic Variation [426]
MCM8 OTC93H3S Strong Altered Expression [427]
MCPH1 OTYT3TT5 Strong Biomarker [428]
MEF2B OT880SE6 Strong Altered Expression [429]
MFF OTEVIXOM Strong Biomarker [430]
MFN1 OTCBXQZF Strong Biomarker [430]
MFN2 OTPYN8A3 Strong Biomarker [276]
MITF OT6XJCZH Strong Genetic Variation [406]
MLXIP OT30UNI7 Strong Genetic Variation [426]
MNDA OTCTKR47 Strong Biomarker [431]
MSC OTBRPZL5 Strong Altered Expression [432]
MSX2 OT1WDKE1 Strong Biomarker [433]
MTHFD1 OTMKHVWC Strong Altered Expression [434]
MYLIP OTL0PFGV Strong Genetic Variation [426]
NBPF3 OTRM16MN Strong Biomarker [255]
NCOA1 OTLIUJQD Strong Biomarker [45]
NCOR1 OT04XNOU Strong Biomarker [45]
NCOR2 OTY917X0 Strong Altered Expression [435]
NCR3LG1 OT15YWU7 Strong Altered Expression [436]
ND4 OT4RQVAA Strong Biomarker [327]
NELFB OTCFH88S Strong Biomarker [168]
NFE2L1 OT1QHOS2 Strong Altered Expression [437]
NFKBIE OTLAYEL9 Strong Genetic Variation [438]
NOL3 OT1K0L0D Strong Biomarker [439]
NRF1 OTOXWNV8 Strong Altered Expression [437]
OCA2 OTDWIGBF Strong Biomarker [77]
OCLN OTSUTVWL Strong Altered Expression [440]
OSBPL3 OT9G194Y Strong Biomarker [441]
OSCP1 OTZ4IFGJ Strong Biomarker [43]
OVOL1 OTFJ62UI Strong Altered Expression [327]
PC OT6O0V51 Strong Posttranslational Modification [442]
PCNP OTJUQ122 Strong Biomarker [443]
PDCD4 OTZ6NXUX Strong Altered Expression [444]
PDCD5 OT6T2DDL Strong Altered Expression [445]
PDIK1L OTISF4KG Strong Biomarker [446]
PIAS1 OTZVAHZI Strong Biomarker [447]
PIDD1 OTWFM930 Strong Biomarker [448]
PLA1A OT2IXYNX Strong Altered Expression [449]
PLIN5 OTV8G50L Strong Altered Expression [450]
PODXL OTPNQXF3 Strong Biomarker [451]
POLD1 OTWO4UCJ Strong Biomarker [107]
POLDIP2 OT8SZSJ6 Strong Posttranslational Modification [76]
POT1 OTNBXJCQ Strong Genetic Variation [452]
PPARGC1A OTHCDQ22 Strong Altered Expression [453]
PRDM1 OTQLSVBS Strong Biomarker [142]
PSMD9 OT6Y5CC3 Strong Altered Expression [344]
PSMG1 OTZ5I6UM Strong Biomarker [75]
PTCD3 OTHTOLE0 Strong Biomarker [454]
PTPN4 OT6SXU5Y Strong Biomarker [455]
PYCR1 OTQHB52T Strong Altered Expression [456]
PYGO2 OTZHB2OI Strong Posttranslational Modification [457]
RAB3D OTGKRR3C Strong Biomarker [458]
RAB5IF OTNNWX7E Strong Biomarker [459]
RANGAP1 OTZGD3LJ Strong Altered Expression [460]
RASGRP1 OTX9WN2E Strong Biomarker [461]
REM1 OTUXL0HC Strong Altered Expression [462]
RERE OT3G4GBZ Strong Altered Expression [73]
REV3L OT0OP8EJ Strong Altered Expression [463]
RFC4 OTWALD2R Strong Genetic Variation [464]
RFX7 OTKFNW3A Strong Genetic Variation [465]
RHOH OT1J9SEB Strong Genetic Variation [466]
RNASEH1 OTT7L25X Strong Altered Expression [467]
RNF19A OTKWCV80 Strong Posttranslational Modification [76]
RPL10 OTBHOZGC Strong Genetic Variation [468]
RPL17 OTTYMPS6 Strong Biomarker [469]
RPS6 OTT4D1LN Strong Biomarker [470]
RRAS OTBBF28C Strong Biomarker [471]
RTL10 OTHGB81W Strong Biomarker [472]
SCIN OT6U09OL Strong Biomarker [473]
SEPTIN2 OT3G33TM Strong Biomarker [200]
SESN2 OT889IXY Strong Altered Expression [474]
SETD3 OTO5RAU2 Strong Genetic Variation [475]
SH2D1A OTLU49I5 Strong Genetic Variation [476]
SHROOM4 OT33GO6E Strong Biomarker [477]
SIRT4 OT5S0J23 Strong Biomarker [478]
SMARCB1 OT2LP7LJ Strong Biomarker [479]
SMIM10L2B OT04IG2N Strong Biomarker [480]
SMURF1 OT5UIZR8 Strong Altered Expression [102]
SOBP OTI8OO0M Strong Genetic Variation [328]
SOX11 OT4LG7LA Strong Biomarker [481]
SOX6 OTT0W0LE Strong Biomarker [482]
SPATA2 OTOA45GL Strong Biomarker [469]
SRA1 OTYOGMTG Strong Genetic Variation [291]
STAT5A OTBSJGN3 Strong Genetic Variation [483]
STAT5B OTZVPEBT Strong Genetic Variation [483]
STIM1 OT8CLQ1W Strong Biomarker [484]
TAT OT2CJ91O Strong Biomarker [149]
TBRG1 OTMV5L8H Strong Biomarker [485]
TCHP OTVDMHSY Strong Altered Expression [486]
TCL1B OT4CSO39 Strong Biomarker [193]
TEAD1 OTK6971C Strong Altered Expression [487]
TET3 OT76U3YF Strong Genetic Variation [488]
THY1 OTVONVTB Strong Altered Expression [489]
TICAM2 OTK7GIJ5 Strong Altered Expression [344]
TLX1 OTVN0MNW Strong Altered Expression [490]
TM4SF1 OTY0ECQN Strong Altered Expression [491]
TMED7 OTONO8E6 Strong Altered Expression [344]
TMEM132D OTV6I4Z0 Strong Biomarker [492]
TNFAIP8 OT1G9297 Strong Altered Expression [76]
TNFSF9 OTV9L89D Strong Altered Expression [493]
TP53AIP1 OT1XVNDP Strong Biomarker [494]
TP53INP1 OT2363Z9 Strong Altered Expression [495]
TRAF1 OTTLM5RU Strong Biomarker [330]
TRAF3 OT5TQBGV Strong Altered Expression [496]
TRIO OT71X1AK Strong Altered Expression [497]
TRMT9B OTU3UPEE Strong Biomarker [419]
TRPV5 OTWF4L0U Strong Altered Expression [498]
TSPAN33 OTH6C0WU Strong Biomarker [499]
TSPYL2 OTGGW2EF Strong Biomarker [500]
AFF1 OTT2C78E Definitive Genetic Variation [501]
BCAP31 OTKSACR4 Definitive Altered Expression [131]
CD2AP OTC76KQM Definitive Genetic Variation [231]
CD99L2 OTQTZFCX Definitive Biomarker [502]
CDK15 OT8S67QS Definitive Altered Expression [242]
CDK16 OTUBXIIT Definitive Altered Expression [242]
CDK5RAP1 OTDEJXD0 Definitive Altered Expression [503]
CDT1 OTVY53VG Definitive Genetic Variation [233]
CEACAM16 OTUMUSY0 Definitive Genetic Variation [231]
CFAP69 OTK73MCA Definitive Posttranslational Modification [504]
CKAP4 OTDUC9ME Definitive Altered Expression [246]
CLDN7 OTNE0XHQ Definitive Altered Expression [305]
COMMD3 OT1UTJH4 Definitive Biomarker [233]
DAP OT5YLL7E Definitive Posttranslational Modification [505]
DEXI OT60W9CN Definitive Altered Expression [506]
DKC1 OTX7DJR6 Definitive Biomarker [507]
DNALI1 OTTB3L8N Definitive Altered Expression [131]
DOHH OTDRAT3F Definitive Biomarker [508]
DSG2 OTJPB2TO Definitive Biomarker [509]
EFNB3 OT12WTXQ Definitive Biomarker [510]
ETV5 OTE2OBM4 Definitive Biomarker [511]
FAU OTGTVOWK Definitive Genetic Variation [512]
FGF3 OT9PK2SI Definitive Genetic Variation [513]
GOSR1 OTX8TMVU Definitive Altered Expression [131]
GZMM OTEC5CWT Definitive Genetic Variation [514]
H6PD OTO7TNDD Definitive Altered Expression [515]
HLA-DOA OTZE5Q7R Definitive Altered Expression [516]
HTN3 OTEUXA81 Definitive Genetic Variation [517]
IFNGR1 OTCTQBWW Definitive Genetic Variation [518]
JAM3 OTX0F9QL Definitive Altered Expression [519]
LBR OT1HG3HG Definitive Biomarker [520]
LCP1 OTK61F2A Definitive Genetic Variation [521]
LYL1 OTCNOV1M Definitive Altered Expression [522]
MAP3K12 OT5HODDD Definitive Biomarker [523]
MCF2 OTB9N93T Definitive Biomarker [524]
MCM3 OTOOHQPM Definitive Altered Expression [243]
MEF2D OT7CEIG0 Definitive Biomarker [523]
MFHAS1 OTS922CJ Definitive Biomarker [525]
MOS OTNMQPFJ Definitive Biomarker [526]
MTBP OTWLCW9C Definitive Altered Expression [527]
MYBL1 OTBJMC2P Definitive Biomarker [528]
MYCL OT1MFQ5U Definitive Biomarker [529]
NAIP OTLA925F Definitive Biomarker [233]
NECTIN2 OTIE0W6O Definitive Biomarker [231]
NR2C2 OTDZWVOJ Definitive Altered Expression [162]
ONECUT2 OTHUE5YY Definitive Posttranslational Modification [504]
PARP9 OT7K4494 Definitive Biomarker [232]
PCGF6 OTSBZOYD Definitive Genetic Variation [233]
PEBP4 OTKDCVC6 Definitive Biomarker [530]
PHB2 OTCAX3AW Definitive Biomarker [308]
PIAS2 OTJLSC3V Definitive Biomarker [531]
PIGR OT6GLSUL Definitive Biomarker [532]
POU2F2 OTPV0J0C Definitive Biomarker [247]
PRC1 OTHD0XS0 Definitive Biomarker [533]
PRF1 OTFVXD7H Definitive Genetic Variation [534]
PRKACG OTKOQYF8 Definitive Altered Expression [242]
PTPRA OTZA82J1 Definitive Altered Expression [245]
PTPRG OT9N2WOF Definitive Altered Expression [262]
PTPRU OTHDO0QG Definitive Genetic Variation [190]
PXN OTVMMUOF Definitive Genetic Variation [535]
RBL1 OTDEBFYC Definitive Genetic Variation [536]
RIT2 OTSNYG0D Definitive Biomarker [537]
RMND1 OT7I6RBT Definitive Biomarker [538]
ROMO1 OTIEYVBW Definitive Biomarker [308]
RUNX1T1 OT30DED5 Definitive Altered Expression [539]
SERPINA9 OT0OIZH1 Definitive Altered Expression [540]
SMURF2 OT3TRVL7 Definitive Genetic Variation [541]
SPI1 OTVCA1D0 Definitive Biomarker [542]
STAP2 OTEB1VVI Definitive Altered Expression [543]
TCEAL7 OTNPDZCN Definitive Altered Expression [544]
TCHH OT4J7EFT Definitive Genetic Variation [545]
TLK1 OTICTXI8 Definitive Altered Expression [242]
TMED5 OT70W1J8 Definitive Altered Expression [131]
TOMM40 OTZDQ29F Definitive Genetic Variation [231]
TRAF2 OT1MEZZN Definitive Altered Expression [546]
------------------------------------------------------------------------------------
⏷ Show the Full List of 401 DOT(s)

References

1 Bortezomib FDA Label
2 Dexamethasone FDA Label
3 Diffuse Large B-Cell Lymphoma and Related Entities. Dtsch Arztebl Int. 2023 Apr 28;120(17):289-296.
4 The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.Drug Des Devel Ther. 2019 Nov 18;13:3919-3928. doi: 10.2147/DDDT.S219788. eCollection 2019.
5 Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.Pharmacogenomics. 2015;16(4):361-72. doi: 10.2217/pgs.14.179.
6 AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis.Nat Commun. 2018 Jan 15;9(1):222. doi: 10.1038/s41467-017-02595-w.
7 Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.Oncol Lett. 2018 Mar;15(3):3178-3184. doi: 10.3892/ol.2017.7644. Epub 2017 Dec 19.
8 Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma.Am J Dermatopathol. 2019 Aug;41(8):602-605. doi: 10.1097/DAD.0000000000001348.
9 Theaflavins prevent cartilage degeneration via AKT/FOXO3 signaling invitro.Mol Med Rep. 2019 Feb;19(2):821-830. doi: 10.3892/mmr.2018.9745. Epub 2018 Dec 12.
10 Autophagy is Required to Regulate Mitochondria Renewal, Cell Attachment, and All-trans-Retinoic Acid-Induced Differentiation in NB4 Acute Promyelocytic Leukemia Cells.J Environ Pathol Toxicol Oncol. 2019;38(1):13-20. doi: 10.1615/JEnvironPatholToxicolOncol.2018027885.
11 Rsf? regulates malignant melanoma cell viability and chemoresistance via NFB/Bcl? signaling.Mol Med Rep. 2019 Oct;20(4):3487-3498. doi: 10.3892/mmr.2019.10610. Epub 2019 Aug 23.
12 Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.Cancer Sci. 2019 May;110(5):1686-1694. doi: 10.1111/cas.13983. Epub 2019 Mar 28.
13 T cells redirected against Ig for the immunotherapy of B cell lymphoma.Leukemia. 2020 Mar;34(3):821-830. doi: 10.1038/s41375-019-0607-5. Epub 2019 Oct 17.
14 Role of the chromobox protein CBX7 in lymphomagenesis.Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5389-94. doi: 10.1073/pnas.0608721104. Epub 2007 Mar 20.
15 Hesperidin modulates dextran sulfate sodium-induced ulcerative colitis in rats: Targeting sphingosine kinase-1- sphingosine 1 phosphate signaling pathway, mitochondrial biogenesis, inflammation, and apoptosis.J Biochem Mol Toxicol. 2019 Jun;33(6):e22312. doi: 10.1002/jbt.22312. Epub 2019 Feb 27.
16 Activation of Toll-like receptor 7 inhibits the proliferation and migration, and induces the apoptosis of pancreatic cancer cells.Mol Med Rep. 2015 Oct;12(4):6079-85. doi: 10.3892/mmr.2015.4130. Epub 2015 Jul 28.
17 Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.J Immunol. 2017 Nov 1;199(9):3116-3128. doi: 10.4049/jimmunol.1700898. Epub 2017 Sep 29.
18 HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy.Mol Cancer Ther. 2019 May;18(5):900-908. doi: 10.1158/1535-7163.MCT-18-1068. Epub 2019 Mar 1.
19 MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-B Pathway.Int J Mol Sci. 2019 Oct 20;20(20):5200. doi: 10.3390/ijms20205200.
20 Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in in vitro and in vivo models of renal cell carcinoma.Oncotarget. 2017 Apr 7;8(34):56311-56326. doi: 10.18632/oncotarget.16910. eCollection 2017 Aug 22.
21 Scoring a HAT-Trick against Lymphoma.Immunity. 2019 Sep 17;51(3):420-423. doi: 10.1016/j.immuni.2019.08.018.
22 Forsythiaside A protects against focal cerebral ischemic injury by mediating the activation of the Nrf2 and endoplasmic reticulum stress pathways.Mol Med Rep. 2019 Aug;20(2):1313-1320. doi: 10.3892/mmr.2019.10312. Epub 2019 May 30.
23 Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia.Ann Hematol. 2016 Sep;95(9):1503-12. doi: 10.1007/s00277-016-2731-x. Epub 2016 Jul 4.
24 The IL-15-Based ALT-803 Complex Enhances FcRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.Clin Cancer Res. 2016 Feb 1;22(3):596-608. doi: 10.1158/1078-0432.CCR-15-1419. Epub 2015 Sep 30.
25 Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.Anticancer Res. 2012 Apr;32(4):1367-73.
26 New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.Oncotarget. 2017 Jul 4;8(27):44366-44378. doi: 10.18632/oncotarget.17875.
27 Silencing of PTGS2 exerts promoting effects on angiogenesis endothelial progenitor cells in mice with ischemic stroke via repression of the NF-B signaling pathway.J Cell Physiol. 2019 Dec;234(12):23448-23460. doi: 10.1002/jcp.28914. Epub 2019 Jun 21.
28 Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjgren's Syndrome.Arthritis Rheumatol. 2018 Aug;70(8):1265-1275. doi: 10.1002/art.40500. Epub 2018 Jun 27.
29 Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?.Oncology. 2018;95(5):257-269. doi: 10.1159/000490106. Epub 2018 Jun 20.
30 Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues.Histopathology. 2017 Jul;71(1):112-124. doi: 10.1111/his.13206. Epub 2017 Apr 26.
31 Phase 1 study of the PI3K inhibitor INCB040093 JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.Blood. 2018 Jul 19;132(3):293-306. doi: 10.1182/blood-2017-10-812701. Epub 2018 Apr 25.
32 MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2/STAT3 signaling pathway.Oncol Lett. 2019 Feb;17(2):2451-2456. doi: 10.3892/ol.2018.9838. Epub 2018 Dec 17.
33 Long Noncoding RNA KCNQ1OT1 Promotes the Progression of Non-Small Cell Lung Cancer via Regulating miR-204-5p/ATG3 Axis.Onco Targets Ther. 2019 Dec 10;12:10787-10797. doi: 10.2147/OTT.S226044. eCollection 2019.
34 Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.Arthritis Rheumatol. 2016 Apr;68(4):901-14. doi: 10.1002/art.39515.
35 LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.Am J Surg Pathol. 2017 Jul;41(7):877-886. doi: 10.1097/PAS.0000000000000839.
36 Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis.J Viral Hepat. 2003 Jul;10(4):241-8. doi: 10.1046/j.1365-2893.2003.00447.x.
37 Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.J Med Chem. 2019 Apr 25;62(8):3971-3988. doi: 10.1021/acs.jmedchem.8b01991. Epub 2019 Apr 16.
38 Pyrrolidine dithiocarbamate sensitizes U251 brain glioma cells to temozolomide via downregulation of MGMT and BCL-XL.Oncol Lett. 2017 Nov;14(5):5135-5144. doi: 10.3892/ol.2017.6849. Epub 2017 Aug 28.
39 Vitexin reverses the autophagy dysfunction to attenuate MCAO-induced cerebral ischemic stroke via mTOR/Ulk1 pathway.Biomed Pharmacother. 2018 Mar;99:583-590. doi: 10.1016/j.biopha.2018.01.067. Epub 2018 Feb 20.
40 MiR-33b-3p promotes chondrocyte proliferation and inhibits chondrocyte apoptosis and cartilage ECM degradation by targeting DNMT3A in osteoarthritis.Biochem Biophys Res Commun. 2019 Nov 5;519(2):430-437. doi: 10.1016/j.bbrc.2019.09.022. Epub 2019 Sep 13.
41 Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization.J Cell Biochem. 2019 Apr;120(4):5695-5703. doi: 10.1002/jcb.27854. Epub 2018 Oct 15.
42 B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection.J Virol. 2019 Dec 12;94(1):e01232-19. doi: 10.1128/JVI.01232-19. Print 2019 Dec 12.
43 B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.J Biol Chem. 2018 Mar 30;293(13):4724-4734. doi: 10.1074/jbc.RA117.001101. Epub 2018 Feb 2.
44 Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.Biochem Biophys Res Commun. 2019 Jan 15;508(3):825-831. doi: 10.1016/j.bbrc.2018.12.004. Epub 2018 Dec 7.
45 Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation.Gynecol Obstet Invest. 2018;83(5):443-454. doi: 10.1159/000480011. Epub 2017 Dec 11.
46 Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemcitabine.Exp Ther Med. 2019 Mar;17(3):1697-1705. doi: 10.3892/etm.2018.7112. Epub 2018 Dec 19.
47 Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.Oncol Lett. 2018 Jan;15(1):1149-1156. doi: 10.3892/ol.2017.7408. Epub 2017 Nov 14.
48 PRMT5 is essential for B cell development and germinal center dynamics.Nat Commun. 2019 Jan 3;10(1):22. doi: 10.1038/s41467-018-07884-6.
49 Knockdown of serpin peptidase inhibitor clade C member1 inhibits the growth of nasopharyngeal carcinoma cells.Mol Med Rep. 2019 May;19(5):3658-3666. doi: 10.3892/mmr.2019.10021. Epub 2019 Mar 14.
50 Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.Neurosurgery. 1994 Jan;34(1):129-35.
51 Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma.Expert Opin Emerg Drugs. 2018 Jun;23(2):111-122. doi: 10.1080/14728214.2018.1479396. Epub 2018 Jun 6.
52 Loss of TNFAIP3 enhances MYD88(L265P)-driven signaling in non-Hodgkin lymphoma.Blood Cancer J. 2018 Oct 9;8(10):97. doi: 10.1038/s41408-018-0130-3.
53 A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.Blood. 2013 Aug 1;122(5):726-33. doi: 10.1182/blood-2013-04-495804. Epub 2013 Jun 17.
54 Expression and function of the transient receptor potential ion channel family in the hematologic malignancies.Curr Mol Pharmacol. 2013 Nov;6(3):137-48. doi: 10.2174/187446720603140415215431.
55 Up-regulation of receptor interaction protein 140 promotes glucolipotoxicity-induced damage in MIN6 cells.Cell Mol Biol (Noisy-le-grand). 2018 Mar 31;64(4):39-45.
56 Shuxuetong injection protects cerebral microvascular endothelial cells against oxygen-glucose deprivation reperfusion.Neural Regen Res. 2019 May;14(5):783-793. doi: 10.4103/1673-5374.249226.
57 Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/-catenin signaling pathways.Exp Ther Med. 2017 Nov;14(5):5057-5062. doi: 10.3892/etm.2017.5165. Epub 2017 Sep 21.
58 Inhibition of WWP2 suppresses proliferation, and induces G1 cell cycle arrest and apoptosis in liver cancer cells.Mol Med Rep. 2016 Mar;13(3):2261-6. doi: 10.3892/mmr.2016.4771. Epub 2016 Jan 13.
59 Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9.J Ethnopharmacol. 2020 Jan 30;247:112256. doi: 10.1016/j.jep.2019.112256. Epub 2019 Oct 3.
60 The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.Leukemia. 2015 Apr;29(4):958-67. doi: 10.1038/leu.2014.291. Epub 2014 Oct 6.
61 Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.Int J Hematol. 2009 May;89(4):497-507. doi: 10.1007/s12185-009-0303-8. Epub 2009 Apr 11.
62 Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e87-e90. doi: 10.1016/j.clml.2017.08.098. Epub 2017 Aug 14.
63 CD95 antigen mutations in hematopoietic malignancies.Leuk Lymphoma. 2001 Sep-Oct;42(5):835-46. doi: 10.3109/10428190109097702.
64 A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma.PLoS One. 2014 Sep 16;9(9):e104249. doi: 10.1371/journal.pone.0104249. eCollection 2014.
65 Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.Blood. 2011 Jan 13;117(2):585-90. doi: 10.1182/blood-2010-07-295097. Epub 2010 Oct 15.
66 Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population.J BUON. 2013 Apr-Jun;18(2):486-90.
67 Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.Diabetes Obes Metab. 2010 Jan;12(1):35-46. doi: 10.1111/j.1463-1326.2009.01093.x. Epub 2009 Sep 16.
68 PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.Blood. 2011 Nov 17;118(20):5517-27. doi: 10.1182/blood-2011-03-344374. Epub 2011 Sep 21.
69 Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.Oncogene. 2017 Oct 19;36(42):5861-5873. doi: 10.1038/onc.2017.182. Epub 2017 Jun 19.
70 High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.Am J Clin Pathol. 2010 Sep;134(3):472-7. doi: 10.1309/AJCPHMYT93HUIZKW.
71 Expression of TRPM8 in human reactive lymphoid tissues and mature B-cell neoplasms.Oncol Lett. 2018 Nov;16(5):5930-5938. doi: 10.3892/ol.2018.9386. Epub 2018 Sep 3.
72 The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.Asian J Androl. 2019 Sep-Oct;21(5):460-467. doi: 10.4103/aja.aja_1_19.
73 Evaluation of ARG protein expression in mature B cell lymphomas compared to non-neoplastic reactive lymph node.Cell Immunol. 2009;259(2):111-6. doi: 10.1016/j.cellimm.2009.06.004. Epub 2009 Jun 6.
74 Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806905. doi: 10.1177/1533033818806905.
75 Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.Oncotarget. 2016 Jan 19;7(3):3461-76. doi: 10.18632/oncotarget.6505.
76 TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis.Oncol Lett. 2019 May;17(5):4667-4674. doi: 10.3892/ol.2019.10076. Epub 2019 Feb 26.
77 HIF-/PKM2 and PI3K-AKT pathways involved in the protection by dexmedetomidine against isoflurane or bupivacaine-induced apoptosis in hippocampal neuronal HT22 cells.Exp Ther Med. 2019 Jan;17(1):63-70. doi: 10.3892/etm.2018.6956. Epub 2018 Nov 12.
78 2B4-SAP signaling is required for the priming of naive CD8(+) T cells by antigen-expressing B cells and B lymphoma cells.Oncoimmunology. 2016 Dec 27;6(2):e1267094. doi: 10.1080/2162402X.2016.1267094. eCollection 2017.
79 Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS).Med Sci Monit. 2018 Feb 2;24:678-686. doi: 10.12659/msm.908786.
80 Hypertension-induced cardiac impairment is reversed by the inhibition of endoplasmic reticulum stress.J Pharm Pharmacol. 2019 Dec;71(12):1809-1821. doi: 10.1111/jphp.13169. Epub 2019 Oct 3.
81 Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway.Med Sci Monit. 2018 Nov 24;24:8481-8488. doi: 10.12659/MSM.911150.
82 p53 Up-regulated Modulator of Apoptosis Induction Mediates Acetaminophen-Induced Necrosis and Liver Injury in Mice.Hepatology. 2019 May;69(5):2164-2179. doi: 10.1002/hep.30422. Epub 2019 Mar 11.
83 The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.PLoS One. 2019 Feb 15;14(2):e0212492. doi: 10.1371/journal.pone.0212492. eCollection 2019.
84 Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.Int J Mol Sci. 2018 Jan 20;19(1):308. doi: 10.3390/ijms19010308.
85 Sodium selenite induces apoptosis via ROS-mediated NF-B signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells.J Cell Physiol. 2019 Mar;234(3):2511-2522. doi: 10.1002/jcp.26783. Epub 2018 Sep 14.
86 BMP? protects retinal pigment epithelial cells from oxidative stressinduced injury by inhibiting the MAPK signaling pathways.Int J Mol Med. 2018 Aug;42(2):1096-1105. doi: 10.3892/ijmm.2018.3675. Epub 2018 May 14.
87 S-allyl-l-cysteine (SAC) protects hepatocytes from alcohol-induced apoptosis.FEBS Open Bio. 2019 Jul;9(7):1327-1336. doi: 10.1002/2211-5463.12684. Epub 2019 Jun 17.
88 Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.Tumour Biol. 2014 Dec;35(12):11771-9. doi: 10.1007/s13277-014-2298-x. Epub 2014 Aug 31.
89 A T Cell-B Cell Tumor-Suppressive Axis in the Germinal Center.Immunity. 2019 Aug 20;51(2):204-206. doi: 10.1016/j.immuni.2019.07.006.
90 Expressions and effects of G250, Bax and Bcl-2 in rats with renal clear cell carcinoma.Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4488-4492. doi: 10.26355/eurrev_201807_15502.
91 FGF21 attenuates hypoxiainduced dysfunction and apoptosis in HPAECs through alleviating endoplasmic reticulum stress.Int J Mol Med. 2018 Sep;42(3):1684-1694. doi: 10.3892/ijmm.2018.3705. Epub 2018 May 24.
92 Expression of miRNA-214 in the sera of elderly patients with acute myocardial infarction and its effect on cardiomyocyte apoptosis.Exp Ther Med. 2019 Jun;17(6):4657-4662. doi: 10.3892/etm.2019.7464. Epub 2019 Apr 3.
93 Selenium Deficiency Aggravates Aflatoxin B1-Induced Immunotoxicity in Chick Spleen by Regulating 6 Selenoprotein Genes and Redox/Inflammation/Apoptotic Signaling.J Nutr. 2019 Jun 1;149(6):894-901. doi: 10.1093/jn/nxz019.
94 MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.Tumour Biol. 2014 Jan;35(1):837-44. doi: 10.1007/s13277-013-1115-2. Epub 2013 Aug 23.
95 Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.J Biol Chem. 2020 Jan 31;295(5):1165-1180. doi: 10.1074/jbc.RA119.008742. Epub 2019 Dec 10.
96 Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Mnster protocols.Haematologica. 2017 Jun;102(6):1091-1098. doi: 10.3324/haematol.2016.156885. Epub 2017 Feb 16.
97 CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.Int J Lab Hematol. 2014 Dec;36(6):650-5. doi: 10.1111/ijlh.12203. Epub 2014 Mar 17.
98 CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.Mod Pathol. 2018 Feb;31(2):327-336. doi: 10.1038/modpathol.2017.135. Epub 2017 Oct 6.
99 CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.
100 Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma.Mol Ther Oncolytics. 2019 Aug 28;15:60-68. doi: 10.1016/j.omto.2019.08.002. eCollection 2019 Dec 20.
101 Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.Blood Adv. 2019 Apr 23;3(8):1230-1243. doi: 10.1182/bloodadvances.2018029678.
102 Knockdown of long noncoding RNA XIST mitigates the apoptosis and inflammatory injury of microglia cells after spinal cord injury through miR-27a/Smurf1 axis.Neurosci Lett. 2020 Jan 10;715:134649. doi: 10.1016/j.neulet.2019.134649. Epub 2019 Nov 25.
103 Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.J Virol. 2017 Mar 13;91(7):e01928-16. doi: 10.1128/JVI.01928-16. Print 2017 Apr 1.
104 De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.Haematologica. 2008 Aug;93(8):1195-202. doi: 10.3324/haematol.12810. Epub 2008 Jun 12.
105 An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies.Methods. 2019 Feb 1;154:70-76. doi: 10.1016/j.ymeth.2018.08.008. Epub 2018 Aug 24.
106 The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.Int J Mol Med. 2019 Jul;44(1):57-66. doi: 10.3892/ijmm.2019.4193. Epub 2019 May 10.
107 Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.Int J Mol Sci. 2018 Oct 31;19(11):3419. doi: 10.3390/ijms19113419.
108 Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p.J Cell Biochem. 2019 Sep;120(9):16283-16292. doi: 10.1002/jcb.28910. Epub 2019 Jun 3.
109 Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6.Oncogene. 2009 Oct 22;28(42):3723-34. doi: 10.1038/onc.2009.230. Epub 2009 Aug 24.
110 CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells.Mol Med Rep. 2015 Sep;12(3):3902-3908. doi: 10.3892/mmr.2015.3871. Epub 2015 May 29.
111 Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).Arch Biochem Biophys. 2019 Aug 15;671:245-254. doi: 10.1016/j.abb.2019.06.009. Epub 2019 Jun 25.
112 Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4.J Biochem. 2018 Jan 1;163(1):61-68. doi: 10.1093/jb/mvx065.
113 Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma.Oncotarget. 2015 Jun 20;6(17):15122-36. doi: 10.18632/oncotarget.3824.
114 The role of high serum CXCL13 level in Waldenstrm macroglobulinemia.Leuk Res. 2019 Jun;81:50-55. doi: 10.1016/j.leukres.2019.04.007. Epub 2019 Apr 17.
115 IL-6 Impairs Vaccine Responses in Neonatal Mice.Front Immunol. 2018 Dec 20;9:3049. doi: 10.3389/fimmu.2018.03049. eCollection 2018.
116 Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.BMC Cancer. 2018 Apr 13;18(1):418. doi: 10.1186/s12885-018-4333-6.
117 MicroRNA-15a modulates lens epithelial cells apoptosis and proliferation through targeting B-cell lymphoma-2 and E2F transcription factor 3 in age-related cataracts.Biosci Rep. 2019 Dec 20;39(12):BSR20191773. doi: 10.1042/BSR20191773.
118 Suppression of tumor cell proliferation and migration by human umbilical cord mesenchymal stem cells: A possible role for apoptosis and Wnt signaling.Oncol Lett. 2018 Jun;15(6):8536-8544. doi: 10.3892/ol.2018.8368. Epub 2018 Mar 28.
119 Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.Mol Med Rep. 2016 Apr;13(4):3190-6. doi: 10.3892/mmr.2016.4904. Epub 2016 Feb 18.
120 The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection.Cell Mol Immunol. 2020 Mar;17(3):247-260. doi: 10.1038/s41423-019-0219-z. Epub 2019 Mar 6.
121 Effects of recombinant activated coagulation factor VII on apoptosis and expressions of Bcl-2 and Bax in rats with intracerebral hemorrhage.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5264-5269. doi: 10.26355/eurrev_201808_15725.
122 TNF--TNFR signal pathway inhibits autophagy and promotes apoptosis of alveolar macrophages in coal worker's pneumoconiosis.J Cell Physiol. 2019 May;234(5):5953-5963. doi: 10.1002/jcp.27061. Epub 2018 Nov 23.
123 Chronic psychological stress impairs germinal center response by repressing miR-155.Brain Behav Immun. 2019 Feb;76:48-60. doi: 10.1016/j.bbi.2018.11.002. Epub 2018 Nov 8.
124 CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.Blood. 2006 Oct 1;108(7):2384-91. doi: 10.1182/blood-2006-05-020602. Epub 2006 Jun 6.
125 A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.Mol Oncol. 2016 Oct;10(8):1232-44. doi: 10.1016/j.molonc.2016.06.001. Epub 2016 Jun 9.
126 Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells.Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3120-3125. doi: 10.1073/pnas.1711335115. Epub 2018 Mar 5.
127 Ocular Effects of Sildenafil in Nave Mice and a Mouse Model of Optic Nerve Crush.Invest Ophthalmol Vis Sci. 2019 May 1;60(6):1987-1995. doi: 10.1167/iovs.18-26333.
128 Knockdown of GluA2 induces apoptosis in non-small-cell lung cancer A549 cells through the p53 signaling pathway.Oncol Lett. 2017 Jul;14(1):1005-1010. doi: 10.3892/ol.2017.6234. Epub 2017 May 24.
129 Reverse translational strategies for developing animal models of bipolar disorder.Dis Model Mech. 2009 May-Jun;2(5-6):238-45. doi: 10.1242/dmm.001628.
130 Effect of alterations in apoptotic pathway on development of metabolic syndrome in patients with psoriasis vulgaris.Br J Dermatol. 2017 Jun;176(6):1549-1557. doi: 10.1111/bjd.15185. Epub 2017 Apr 10.
131 Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas.J Pathol. 2006 Jul;209(3):360-8. doi: 10.1002/path.1995.
132 Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.Blood. 2006 Jan 15;107(2):760-8. doi: 10.1182/blood-2005-05-1929. Epub 2005 Sep 27.
133 Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma.Exp Hematol. 2019 Oct;78:46-55.e3. doi: 10.1016/j.exphem.2019.09.023. Epub 2019 Sep 24.
134 Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9.Cell Death Dis. 2018 Feb 2;9(2):150. doi: 10.1038/s41419-017-0240-z.
135 HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-B signaling pathway.Oncol Lett. 2018 Mar;15(3):3883-3889. doi: 10.3892/ol.2018.7800. Epub 2018 Jan 16.
136 Paradoxical effect of testosterone supplementation therapy on cardiac ischemia/reperfusion injury in aged rats.J Steroid Biochem Mol Biol. 2019 Jul;191:105335. doi: 10.1016/j.jsbmb.2019.03.012. Epub 2019 Mar 28.
137 HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.Cancer Genet. 2012 Jul-Aug;205(7-8):356-64. doi: 10.1016/j.cancergen.2012.04.006.
138 Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.Inflamm Bowel Dis. 2019 Mar 14;25(4):756-766. doi: 10.1093/ibd/izy289.
139 Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha.Ann Oncol. 2006 Jan;17(1):110-6. doi: 10.1093/annonc/mdj064. Epub 2005 Nov 15.
140 Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.PLoS One. 2015 Oct 8;10(10):e0139329. doi: 10.1371/journal.pone.0139329. eCollection 2015.
141 Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.Blood Adv. 2019 Apr 9;3(7):984-994. doi: 10.1182/bloodadvances.2018027474.
142 Adiponectin promotes fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cells response in rheumatoid arthritis.Clin Exp Rheumatol. 2020 Jan-Feb;38(1):11-18. Epub 2019 Apr 11.
143 Effects of melanoma differentiation associated gene-7 (MDA-7/IL-24) on apoptosis of liver cancer cells via regulating the expression of B-cell lymphoma-2.Oncol Lett. 2019 Jul;18(1):29-34. doi: 10.3892/ol.2019.10298. Epub 2019 May 2.
144 Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.Cytometry B Clin Cytom. 2011 Mar;80(2):91-9. doi: 10.1002/cyto.b.20561. Epub 2010 Aug 31.
145 The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes.Diabetologia. 2019 Jan;62(1):87-98. doi: 10.1007/s00125-018-4750-8. Epub 2018 Oct 18.
146 CD56(bright) NK IL-7R expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.J Leukoc Biol. 2017 Jul;102(1):171-184. doi: 10.1189/jlb.5A1116-456R. Epub 2017 Apr 11.
147 Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.J Hepatol. 2011 Jan;54(1):142-52. doi: 10.1016/j.jhep.2010.06.021. Epub 2010 Aug 27.
148 Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.PLoS One. 2016 Dec 1;11(12):e0167650. doi: 10.1371/journal.pone.0167650. eCollection 2016.
149 IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.Cell Death Dis. 2013 May 16;4(5):e632. doi: 10.1038/cddis.2013.140.
150 Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma.Eur J Med Chem. 2018 Jan 1;143:1847-1857. doi: 10.1016/j.ejmech.2017.10.080. Epub 2017 Nov 14.
151 Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.J Control Release. 2017 Oct 10;263:139-150. doi: 10.1016/j.jconrel.2016.12.025. Epub 2016 Dec 24.
152 Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.Oncogene. 2017 Mar;36(11):1537-1545. doi: 10.1038/onc.2016.320. Epub 2016 Oct 3.
153 MicroRNA??p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.Int J Mol Med. 2019 Mar;43(3):1417-1429. doi: 10.3892/ijmm.2019.4062. Epub 2019 Jan 14.
154 Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?.Diagn Mol Pathol. 2002 Mar;11(1):2-8. doi: 10.1097/00019606-200203000-00002.
155 Genetically re-engineered K562cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.Exp Hematol. 2017 Feb;46:38-47. doi: 10.1016/j.exphem.2016.10.003. Epub 2016 Oct 17.
156 A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models.Oncotarget. 2017 Dec 1;8(67):111495-111507. doi: 10.18632/oncotarget.22847. eCollection 2017 Dec 19.
157 Role of putrescine in ovary and embryo development in fruit bat Cynopterus sphinx during embryonic diapause.Mol Reprod Dev. 2019 Dec;86(12):1963-1980. doi: 10.1002/mrd.23281. Epub 2019 Oct 3.
158 Gene expression and angiotropism in primary CNS lymphoma.Blood. 2006 May 1;107(9):3716-23. doi: 10.1182/blood-2005-03-0897. Epub 2006 Jan 17.
159 Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.Int J Cancer. 2020 Mar 15;146(6):1618-1630. doi: 10.1002/ijc.32567. Epub 2019 Jul 25.
160 Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.Exp Ther Med. 2017 Jul;14(1):338-343. doi: 10.3892/etm.2017.4464. Epub 2017 May 17.
161 Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type.Genes Chromosomes Cancer. 2000 Dec;29(4):281-91. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1036>3.0.co;2-i.
162 Novel phosphorylated TAK1 species with functional impact on NF-B and -catenin signaling in human Cutaneous T-cell lymphoma.Leukemia. 2018 Oct;32(10):2211-2223. doi: 10.1038/s41375-018-0066-4. Epub 2018 Feb 22.
163 A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphoma.Genes Chromosomes Cancer. 2006 Sep;45(9):863-73. doi: 10.1002/gcc.20350.
164 Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway.Int J Mol Med. 2018 Dec;42(6):3093-3104. doi: 10.3892/ijmm.2018.3868. Epub 2018 Sep 7.
165 Retracted: EBF1 gene promotes the proliferation and inhibits the apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome through negative regulation of mitogen-activated protein kinase axis.J Cell Biochem. 2019 Feb;120(2):1407-1419. doi: 10.1002/jcb.27177. Epub 2018 Oct 18.
166 Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes.Diabetes Metab Res Rev. 2020 Feb;36(2):e3212. doi: 10.1002/dmrr.3212. Epub 2019 Sep 2.
167 Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2.Oncol Lett. 2017 Dec;14(6):7745-7752. doi: 10.3892/ol.2017.7242. Epub 2017 Oct 20.
168 Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.PLoS Biol. 2018 May 11;16(5):e2002912. doi: 10.1371/journal.pbio.2002912. eCollection 2018 May.
169 Evaluation of Stem Cell Marker Expression in Canine B-Cell Lymphoma Cell Lines, B-Cell Lymphoma-generated Spheres and Primary Samples.Anticancer Res. 2015 May;35(5):2805-16.
170 High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts.Lab Invest. 2002 Jul;82(7):893-901. doi: 10.1097/01.lab.0000020419.25365.c4.
171 Identification of Pax5 as a target of MTA1 in B-cell lymphomas.Cancer Res. 2007 Aug 1;67(15):7132-8. doi: 10.1158/0008-5472.CAN-07-0750.
172 miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.Tumour Biol. 2016 Apr;37(4):5203-11. doi: 10.1007/s13277-015-4390-2. Epub 2015 Nov 9.
173 Sustained delivery of insulin-loaded block copolymers: Potential implications on renal ischemia/reperfusion injury in diabetes mellitus.Biomed Pharmacother. 2017 Jul;91:534-545. doi: 10.1016/j.biopha.2017.04.118. Epub 2017 May 5.
174 Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.Leukemia. 2020 Jan;34(1):138-150. doi: 10.1038/s41375-019-0503-z. Epub 2019 Jun 6.
175 cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer Independent.Cell Rep. 2017 Mar 21;18(12):2918-2931. doi: 10.1016/j.celrep.2017.02.067.
176 Implantation of Endothelial Cells with Mesenchymal Stem Cells Accelerates Dental Pulp Tissue Regeneration/Healing in Pulpotomized Rat Molars.J Endod. 2017 Jun;43(6):943-948. doi: 10.1016/j.joen.2017.01.035. Epub 2017 Apr 14.
177 Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.Blood. 1994 Dec 1;84(11):3850-60.
178 Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.Blood. 2010 May 20;115(20):4061-70. doi: 10.1182/blood-2008-06-163386. Epub 2010 Mar 11.
179 Complex effects of Ras proto-oncogenes in tumorigenesis.Carcinogenesis. 2004 Apr;25(4):535-9. doi: 10.1093/carcin/bgh026. Epub 2003 Nov 21.
180 Leonurine promotes neurite outgrowth and neurotrophic activity by modulating the GR/SGK1 signaling pathway in cultured PC12 cells.Neuroreport. 2019 Mar 6;30(4):247-254. doi: 10.1097/WNR.0000000000001180.
181 MicroRNA-191-5p diminished sepsis-induced acute kidney injury through targeting oxidative stress responsive 1 in rat models.Biosci Rep. 2019 Aug 13;39(8):BSR20190548. doi: 10.1042/BSR20190548. Print 2019 Aug 30.
182 Natural Antioxidant Resveratrol Suppresses Uterine Fibroid Cell Growth and Extracellular Matrix Formation In Vitro and In Vivo.Antioxidants (Basel). 2019 Apr 12;8(4):99. doi: 10.3390/antiox8040099.
183 B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition.Autophagy. 2017 Jun 3;13(6):1082-1083. doi: 10.1080/15548627.2017.1304871. Epub 2017 Mar 28.
184 microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells.Open Med (Wars). 2019 Jan 16;14:41-51. doi: 10.1515/med-2019-0007. eCollection 2018.
185 The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma.Leuk Lymphoma. 2019 Dec;60(13):3214-3224. doi: 10.1080/10428194.2019.1633629. Epub 2019 Jul 1.
186 Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma.Leuk Res. 2018 Jan;64:1-9. doi: 10.1016/j.leukres.2017.11.001. Epub 2017 Nov 11.
187 PEP?glutaredoxin 1 protects against hippocampal neuronal cell damage from oxidative stress via regulation of MAPK and apoptotic signaling pathways.Mol Med Rep. 2018 Aug;18(2):2216-2228. doi: 10.3892/mmr.2018.9176. Epub 2018 Jun 15.
188 Knockdown of PKC expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3.J Mol Neurosci. 2015 Jan;55(1):21-31. doi: 10.1007/s12031-014-0341-4. Epub 2014 Jun 4.
189 Ethanol increases manganese-Induced spatial learning and memory deficits via oxidative/nitrosative stress induced p53 dependent/independent hippocampal apoptosis.Toxicology. 2019 Apr 15;418:51-61. doi: 10.1016/j.tox.2019.03.001. Epub 2019 Mar 5.
190 TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.Cytokine. 2016 Jun;82:52-7. doi: 10.1016/j.cyto.2015.12.025. Epub 2016 Jan 23.
191 In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).BMC Genomics. 2014 May 21;15(1):390. doi: 10.1186/1471-2164-15-390.
192 BCL-xL/MCL-1 inhibition and RAR antagonism work cooperatively in human HL60 leukemia cells.Exp Cell Res. 2014 Oct 1;327(2):183-91. doi: 10.1016/j.yexcr.2014.07.024. Epub 2014 Aug 1.
193 The NF-B subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.Oncogene. 2016 Jun 30;35(26):3476-84. doi: 10.1038/onc.2015.399. Epub 2015 Nov 2.
194 Docking-based inverse virtual screening strategy for identification of novel protein targets for triclosan.Chemosphere. 2019 Nov;235:976-984. doi: 10.1016/j.chemosphere.2019.07.027. Epub 2019 Jul 4.
195 Non-canonical NF-B Plays a Pivotal Role in Non-Hodgkin's Lymphoma.Cell Biochem Biophys. 2015 Jul;72(3):681-5. doi: 10.1007/s12013-015-0518-7.
196 Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells.Blood. 2008 Feb 1;111(3):1644-53. doi: 10.1182/blood-2007-05-088591. Epub 2007 Nov 19.
197 Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Blood. 2016 Apr 28;127(17):2144-54. doi: 10.1182/blood-2015-10-678706. Epub 2016 Mar 16.
198 Schisandra chinensis acidic polysaccharide partialy reverses acetaminophen-induced liver injury in mice.J Pharmacol Sci. 2019 Jul;140(3):248-254. doi: 10.1016/j.jphs.2019.07.008. Epub 2019 Jul 24.
199 Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.BMC Cancer. 2019 Nov 29;19(1):1160. doi: 10.1186/s12885-019-6381-y.
200 Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.Lancet Haematol. 2019 Feb;6(2):e100-e109. doi: 10.1016/S2352-3026(18)30216-3.
201 MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor -activated kinase 1.Mol Med Rep. 2017 Jul;16(1):755-763. doi: 10.3892/mmr.2017.6640. Epub 2017 May 29.
202 Deficiency of FcR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice.Endocrinology. 2015 Nov;156(11):4047-58. doi: 10.1210/en.2015-1184. Epub 2015 Aug 21.
203 TGF--induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.BMC Immunol. 2010 Nov 23;11:57. doi: 10.1186/1471-2172-11-57.
204 The impact of SOCS1 mutations in diffuse large B-cell lymphoma.Br J Haematol. 2019 Dec;187(5):627-637. doi: 10.1111/bjh.16147. Epub 2019 Aug 12.
205 Coordinated regulation of skeletal muscle mass and metabolic plasticity during recovery from disuse.FASEB J. 2019 Jan;33(1):1288-1298. doi: 10.1096/fj.201701403RRR. Epub 2018 Aug 22.
206 STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.Oncogene. 2013 Nov 7;32(45):5283-91. doi: 10.1038/onc.2012.543. Epub 2012 Nov 26.
207 Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress.Am J Pathol. 2009 Oct;175(4):1653-61. doi: 10.2353/ajpath.2009.090091. Epub 2009 Aug 28.
208 The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.Blood. 2019 Feb 28;133(9):962-966. doi: 10.1182/blood-2018-07-864025. Epub 2018 Dec 19.
209 T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.Biomed Pharmacother. 2017 Apr;88:924-930. doi: 10.1016/j.biopha.2017.01.128. Epub 2017 Feb 6.
210 TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.Cancer Immunol Res. 2019 Mar;7(3):355-362. doi: 10.1158/2326-6066.CIR-18-0351. Epub 2019 Jan 18.
211 Bax inhibitor-1 overexpression in prelimbic cortex protects rats against depression-like behavior induced by olfactory bulbectomy and reduces apoptotic and inflammatory signals.Neurol Res. 2019 Apr;41(4):369-377. doi: 10.1080/01616412.2019.1565649. Epub 2019 Feb 8.
212 Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.Nutrients. 2015 May 5;7(5):3200-18. doi: 10.3390/nu7053200.
213 Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.Eur J Pharmacol. 2019 Mar 15;847:91-96. doi: 10.1016/j.ejphar.2019.01.028. Epub 2019 Jan 25.
214 Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.Methods Mol Biol. 2015;1297:169-85. doi: 10.1007/978-1-4939-2562-9_12.
215 CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.Mol Ther. 2018 Aug 1;26(8):1906-1920. doi: 10.1016/j.ymthe.2018.06.012. Epub 2018 Jun 18.
216 Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.Sci Rep. 2018 Feb 2;8(1):2278. doi: 10.1038/s41598-018-20656-y.
217 APRIL and BAFF: novel biomarkers for central nervous system lymphoma.J Hematol Oncol. 2019 Oct 15;12(1):102. doi: 10.1186/s13045-019-0796-4.
218 Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.Cell Mol Immunol. 2010 Jul;7(4):296-305. doi: 10.1038/cmi.2010.15. Epub 2010 Apr 26.
219 Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.Exp Ther Med. 2019 Sep;18(3):1863-1869. doi: 10.3892/etm.2019.7720. Epub 2019 Jul 1.
220 Expression of TRIM28 correlates with proliferation and Bortezomib-induced apoptosis in B-cell non-Hodgkin lymphoma.Leuk Lymphoma. 2018 Nov;59(11):2639-2649. doi: 10.1080/10428194.2018.1452207. Epub 2018 Mar 23.
221 TRPM4 channel and cancer.Cancer Lett. 2019 Jul 10;454:66-69. doi: 10.1016/j.canlet.2019.04.012. Epub 2019 Apr 10.
222 Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjgren's syndrome.Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):55-64. Epub 2019 Aug 27.
223 Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H(2)O(2))-mediated oxidative stress.Free Radic Biol Med. 2019 Nov 1;143:494-509. doi: 10.1016/j.freeradbiomed.2019.08.025. Epub 2019 Aug 22.
224 USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model.Exp Hematol. 2019 Apr;72:1-8. doi: 10.1016/j.exphem.2019.01.001. Epub 2019 Jan 9.
225 Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.Front Oncol. 2017 Jul 31;7:154. doi: 10.3389/fonc.2017.00154. eCollection 2017.
226 EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas.Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):725-730. doi: 10.1097/PAI.0000000000000820.
227 Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes.Oncol Lett. 2017 Jan;13(1):206-214. doi: 10.3892/ol.2016.5402. Epub 2016 Nov 21.
228 Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.Exp Ther Med. 2019 Aug;18(2):1350-1356. doi: 10.3892/etm.2019.7701. Epub 2019 Jun 21.
229 Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas.PLoS One. 2012;7(11):e49305. doi: 10.1371/journal.pone.0049305. Epub 2012 Nov 14.
230 High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.Am J Pathol. 1999 Jun;154(6):1685-91. doi: 10.1016/S0002-9440(10)65424-7.
231 Gene signature in Alzheimer's disease and environmental factors: the virus chronicle.J Alzheimers Dis. 2011;27(4):809-17. doi: 10.3233/JAD-2011-110755.
232 BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.Blood. 2000 Dec 15;96(13):4328-34.
233 Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.Haematologica. 2008 May;93(5):670-9. doi: 10.3324/haematol.12221. Epub 2008 Mar 26.
234 Development of consensus fluorogenically labeled probes of the immunoglobulin heavy-chain gene for detecting minimal residual disease in B-cell non-Hodgkin lymphomas.Cancer Sci. 2003 Oct;94(10):877-85. doi: 10.1111/j.1349-7006.2003.tb01370.x.
235 An (8;14)(q24;q11) translocation involving the T-cell receptor alpha-chain gene and the MYC oncogene 3' region in a B-cell lymphoma.Genes Chromosomes Cancer. 1989 Sep;1(1):15-22. doi: 10.1002/gcc.2870010105.
236 Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.J Cancer Res Clin Oncol. 2011 Nov;137(11):1629-40. doi: 10.1007/s00432-011-1037-6. Epub 2011 Aug 23.
237 The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan.MAbs. 2011 Sep-Oct;3(5):479-86. doi: 10.4161/mabs.3.5.17228. Epub 2011 Sep 1.
238 The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.Cancer. 2008 Feb 1;112(3):552-61. doi: 10.1002/cncr.23196.
239 The IL-15R alpha chain signals through association with Syk in human B cells.J Immunol. 2001 Dec 1;167(11):6292-302. doi: 10.4049/jimmunol.167.11.6292.
240 The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.Oncogene. 2006 Aug 17;25(36):5056-62. doi: 10.1038/sj.onc.1209510. Epub 2006 Mar 27.
241 Mesencephalic astrocyte-derived neurotrophic factor affords neuroprotection to early brain injury induced by subarachnoid hemorrhage via activating Akt-dependent prosurvival pathway and defending blood-brain barrier integrity.FASEB J. 2019 Feb;33(2):1727-1741. doi: 10.1096/fj.201800227RR. Epub 2018 Sep 13.
242 Effects of propofol on proliferation and anti-apoptosis of neuroblastoma SH-SY5Y cell line: new insights into neuroprotection.Brain Res. 2011 Apr 12;1384:42-50. doi: 10.1016/j.brainres.2011.02.004. Epub 2011 Feb 25.
243 Transcription regulation network analysis of MCF7 breast cancer cells exposed to estradiol.Asian Pac J Cancer Prev. 2012;13(8):3681-5. doi: 10.7314/apjcp.2012.13.8.3681.
244 Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.Genes Chromosomes Cancer. 2003 Aug;37(4):421-6. doi: 10.1002/gcc.10231.
245 Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls.Pediatr Hematol Oncol. 2008 Sep;25(6):528-40. doi: 10.1080/08880010802237054.
246 Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.Diagn Pathol. 2019 Dec 12;14(1):133. doi: 10.1186/s13000-019-0918-x.
247 J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.Hum Pathol. 2017 Oct;68:47-53. doi: 10.1016/j.humpath.2017.08.015. Epub 2017 Aug 26.
248 TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma.Blood. 2012 May 24;119(21):4949-52. doi: 10.1182/blood-2012-02-414441. Epub 2012 Apr 11.
249 Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.Haematologica. 2005 Nov;90(11):1524-32.
250 Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells.Cell Death Differ. 2012 Dec;19(12):1928-38. doi: 10.1038/cdd.2012.71. Epub 2012 Jun 15.
251 Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas.Leuk Lymphoma. 2007 Nov;48(11):2213-20. doi: 10.1080/10428190701632822.
252 Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.Immunology. 2009 Nov;128(3):360-8. doi: 10.1111/j.1365-2567.2009.03111.x.
253 Reduced proliferation and increased apoptosis of the SGC?901 gastric cancer cell line on exposure to GDC?449.Mol Med Rep. 2016 Feb;13(2):1434-40. doi: 10.3892/mmr.2015.4677. Epub 2015 Dec 11.
254 Knockdown of Zinc Transporter ZIP5 by RNA Interference Inhibits Esophageal Cancer Growth In Vivo.Oncol Res. 2016;24(3):205-14. doi: 10.3727/096504016X14648701447896.
255 Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.Haematologica. 2018 Jun;103(6):1065-1072. doi: 10.3324/haematol.2017.175687. Epub 2017 Nov 30.
256 Evidence of altered depression and dementia-related proteins in the brains of young rats after ovariectomy.J Neurochem. 2018 Sep;146(6):703-721. doi: 10.1111/jnc.14537. Epub 2018 Aug 9.
257 R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.Oncol Res Treat. 2018;41(9):534-538. doi: 10.1159/000489717. Epub 2018 Aug 8.
258 The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.Eur J Haematol. 2010 Jan 1;84(1):47-51. doi: 10.1111/j.1600-0609.2009.01344.x. Epub 2009 Sep 8.
259 Glycine Decarboxylase Expression Increased in p53-Mutated B Cell Lymphoma Mice.Oncol Res Treat. 2015;38(11):586-9. doi: 10.1159/000441595. Epub 2015 Oct 23.
260 Cadmium induces apoptotic program imbalance and cell cycle inhibitor expression in cultured human astrocytes.Environ Toxicol Pharmacol. 2019 Jan;65:53-59. doi: 10.1016/j.etap.2018.12.001. Epub 2018 Dec 3.
261 Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin.Blood. 2018 Mar 22;131(12):1325-1336. doi: 10.1182/blood-2017-07-794875. Epub 2018 Feb 1.
262 Epigenetic deregulation in pediatric acute lymphoblastic leukemia.Epigenetics. 2014 Mar;9(3):459-67. doi: 10.4161/epi.27585. Epub 2014 Jan 6.
263 Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-X(L).J Biol Chem. 2018 Dec 21;293(51):19546-19558. doi: 10.1074/jbc.RA118.003061. Epub 2018 Nov 14.
264 Bag-1 Silence Sensitizes Non-Small Cell Lung Cancer Cells To Cisplatin Through Multiple Gene Pathways.Onco Targets Ther. 2019 Oct 31;12:8977-8989. doi: 10.2147/OTT.S218182. eCollection 2019.
265 Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B-cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3.Oncol Lett. 2019 Apr;17(4):3719-3726. doi: 10.3892/ol.2019.10029. Epub 2019 Feb 8.
266 Long noncoding RNA NEAT1 sponges miR?25a?p to suppress cardiomyocyte apoptosis via BCL2L12.Mol Med Rep. 2019 May;19(5):4468-4474. doi: 10.3892/mmr.2019.10095. Epub 2019 Mar 27.
267 Apoptosis of pancreatic -cells in Type 1 diabetes.Bosn J Basic Med Sci. 2017 Aug 20;17(3):183-193. doi: 10.17305/bjbms.2017.1961.
268 p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status.Hum Pathol. 2019 Apr;86:21-31. doi: 10.1016/j.humpath.2018.11.015. Epub 2018 Nov 26.
269 Complement factor Hrelated 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis.Mol Med Rep. 2019 Sep;20(3):2694-2702. doi: 10.3892/mmr.2019.10514. Epub 2019 Jul 23.
270 MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.Med Sci Monit. 2016 May 6;22:1540-6. doi: 10.12659/msm.898121.
271 Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6.
272 NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment.Oncoimmunology. 2017 Dec 20;7(4):e1409322. doi: 10.1080/2162402X.2017.1409322. eCollection 2018.
273 UVB radiation represses CYLD expression in melanocytes.Oncol Lett. 2017 Dec;14(6):7262-7268. doi: 10.3892/ol.2017.7120. Epub 2017 Oct 3.
274 Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.Eur J Haematol. 2020 Jan;104(1):59-66. doi: 10.1111/ejh.13337. Epub 2019 Oct 27.
275 Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.Mol Carcinog. 2018 May;57(5):579-589. doi: 10.1002/mc.22781. Epub 2018 Jan 30.
276 Downregulation of sonic hedgehog signaling in the hippocampus leads to neuronal apoptosis in high-fat diet-fed mice.Behav Brain Res. 2019 Jul 23;367:91-100. doi: 10.1016/j.bbr.2019.03.055. Epub 2019 Mar 30.
277 Effect of lanthanum chloride on tumor growth and apoptosis in human ovarian cancer cells and xenograft animal models.Exp Ther Med. 2018 Aug;16(2):1143-1148. doi: 10.3892/etm.2018.6299. Epub 2018 Jun 13.
278 Downregulation of ENDOCAN in myeloid leukemia cells inhibits proliferation and promotes apoptosis by suppressing nuclear factorB activity.Mol Med Rep. 2019 Apr;19(4):3247-3254. doi: 10.3892/mmr.2019.9969. Epub 2019 Feb 19.
279 Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.Clin Cancer Res. 2005 Jan 1;11(1):87-96.
280 Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.Mod Pathol. 2008 Jun;21(6):653-9. doi: 10.1038/modpathol.2008.30. Epub 2008 Feb 8.
281 Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in extrahepatic cholangiocarcinoma.Cancer Invest. 2010 Jun;28(5):472-8. doi: 10.3109/07357900903095714.
282 Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.Viruses. 2015 Dec 23;8(1):3. doi: 10.3390/v8010003.
283 Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.Int J Cancer. 2005 Jan 10;113(2):207-12. doi: 10.1002/ijc.20562.
284 Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.Am J Dermatopathol. 1997 Aug;19(4):391-5. doi: 10.1097/00000372-199708000-00012.
285 KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.Cell Cycle. 2019 Feb;18(3):249-256. doi: 10.1080/15384101.2019.1568765. Epub 2019 Jan 24.
286 The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.Nat Med. 2015 Oct;21(10):1199-208. doi: 10.1038/nm.3943. Epub 2015 Sep 14.
287 The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.Oncotarget. 2016 Nov 22;7(47):77444-77456. doi: 10.18632/oncotarget.12680.
288 Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.Mod Pathol. 2018 Feb;31(2):313-326. doi: 10.1038/modpathol.2017.134. Epub 2017 Oct 6.
289 The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.Diabetologia. 2016 Oct;59(10):2145-55. doi: 10.1007/s00125-016-4042-0. Epub 2016 Jul 9.
290 Roles of miR-494 in Intervertebral Disk Degeneration and the Related Mechanism.World Neurosurg. 2018 Dec 30:S1878-8750(18)32921-8. doi: 10.1016/j.wneu.2018.12.098. Online ahead of print.
291 Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1.PLoS One. 2019 Aug 23;14(8):e0220715. doi: 10.1371/journal.pone.0220715. eCollection 2019.
292 PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.Genes Chromosomes Cancer. 2013 Nov;52(11):1030-41. doi: 10.1002/gcc.22098. Epub 2013 Aug 9.
293 Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis.Anticancer Agents Med Chem. 2020;20(4):504-517. doi: 10.2174/1871520619666191112114340.
294 Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.World J Gastroenterol. 2019 Nov 7;25(41):6205-6221. doi: 10.3748/wjg.v25.i41.6205.
295 Streptozotocin-Induced Autophagy Reduces Intracellular Insulin in Insulinoma INS-1E Cells.DNA Cell Biol. 2018 Mar;37(3):160-167. doi: 10.1089/dna.2017.3874. Epub 2018 Feb 27.
296 Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.BMJ Case Rep. 2018 Mar 16;2018:bcr2017223637. doi: 10.1136/bcr-2017-223637.
297 Hepatitis B Virus-Upregulated LNC-HUR1 Promotes Cell Proliferation and Tumorigenesis by Blocking p53 Activity.Hepatology. 2018 Dec;68(6):2130-2144. doi: 10.1002/hep.30098. Epub 2018 Sep 19.
298 Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1.Oncol Lett. 2018 Jun;15(6):8687-8694. doi: 10.3892/ol.2018.8397. Epub 2018 Mar 30.
299 Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro.Exp Ther Med. 2017 Jun;13(6):3209-3216. doi: 10.3892/etm.2017.4443. Epub 2017 May 8.
300 Tripartite motifcontaining11 regulates the proliferation and apoptosis of breast cancer cells.Oncol Rep. 2019 Apr;41(4):2567-2574. doi: 10.3892/or.2019.7015. Epub 2019 Feb 14.
301 Protocadherin A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth.Mol Med Rep. 2016 Nov;14(5):4622-4628. doi: 10.3892/mmr.2016.5808. Epub 2016 Oct 5.
302 BAX is an essential key mediator of AP5M1-induced apoptosis in cervical carcinoma cells.Biochem Biophys Res Commun. 2019 Oct 15;518(2):368-373. doi: 10.1016/j.bbrc.2019.08.065. Epub 2019 Aug 16.
303 Autophagy-related protein 12 associates with anti-apoptotic B cell lymphoma-2 to promote apoptosis in gentamicin-induced inner ear hair cell loss.Mol Med Rep. 2017 Jun;15(6):3819-3825. doi: 10.3892/mmr.2017.6458. Epub 2017 Apr 11.
304 Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model.Oncotarget. 2018 Mar 23;9(22):15942-15951. doi: 10.18632/oncotarget.24639. eCollection 2018 Mar 23.
305 Effects of claudin-1 downregulation on the physiological processes of gallbladder cancer SGC996 cells.Oncol Lett. 2019 Feb;17(2):1688-1694. doi: 10.3892/ol.2018.9740. Epub 2018 Nov 21.
306 Activation of the mammalian target of rapamycin signaling pathway underlies a novel inhibitory role of ring finger protein 182 in ventricular remodeling after myocardial ischemia-reperfusion injury.J Cell Biochem. 2019 May;120(5):7635-7648. doi: 10.1002/jcb.28038. Epub 2018 Nov 18.
307 Downregulated microRNA-340-5p promotes proliferation and inhibits apoptosis of chondrocytes in osteoarthritis mice through inhibiting the extracellular signal-regulated kinase signaling pathway by negatively targeting the FMOD gene.J Cell Physiol. 2018 Jan;234(1):927-939. doi: 10.1002/jcp.26921. Epub 2018 Aug 24.
308 Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats.Stroke. 2019 Apr;50(4):978-988. doi: 10.1161/STROKEAHA.118.021590.
309 HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas.Blood. 1997 Nov 15;90(10):4116-25.
310 Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.Anticancer Res. 2017 Aug;37(8):4455-4468. doi: 10.21873/anticanres.11841.
311 Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo.Front Pharmacol. 2018 Sep 18;9:1045. doi: 10.3389/fphar.2018.01045. eCollection 2018.
312 Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activationdependent apoptosis.Oncol Rep. 2018 Sep;40(3):1487-1494. doi: 10.3892/or.2018.6544. Epub 2018 Jul 4.
313 The protective effect of PRMT6 overexpression on cigarette smoke extract-induced murine emphysema model.Int J Chron Obstruct Pulmon Dis. 2017 Nov 3;12:3245-3254. doi: 10.2147/COPD.S144881. eCollection 2017.
314 SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.Haematologica. 2014 Aug;99(8):1356-64. doi: 10.3324/haematol.2013.100230. Epub 2014 May 23.
315 Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.Int J Oncol. 2008 Sep;33(3):549-54.
316 The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.Genes Chromosomes Cancer. 2012 Apr;51(4):338-43. doi: 10.1002/gcc.21919.
317 Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations.J Virol. 2002 Sep;76(18):9046-59. doi: 10.1128/jvi.76.18.9046-9059.2002.
318 Inhibitory effects of PGA1 and TRI on the apoptosis of cardiac microvascular endothelial cells of rats.Exp Ther Med. 2017 Nov;14(5):4288-4292. doi: 10.3892/etm.2017.5079. Epub 2017 Aug 30.
319 Autophagy and apoptosis are regulated by stress on Bcl2 by AMBRA1 in the endoplasmic reticulum and mitochondria.Theor Biol Med Model. 2019 Oct 29;16(1):18. doi: 10.1186/s12976-019-0113-5.
320 Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.Int J Mol Med. 2015 Sep;36(3):627-32. doi: 10.3892/ijmm.2015.2267. Epub 2015 Jun 30.
321 Calotropin regulates the apoptosis of nonsmall cell cancer by regulating the cytotoxic Tlymphocyte associated antigen 4mediated TGF?ERK signaling pathway.Mol Med Rep. 2018 Jun;17(6):7683-7691. doi: 10.3892/mmr.2018.8853. Epub 2018 Apr 5.
322 Postnatal changes in the development of rat submandibular glands in offspring of diabetic mothers: Biochemical, histological and ultrastructural study.PLoS One. 2018 Oct 10;13(10):e0205372. doi: 10.1371/journal.pone.0205372. eCollection 2018.
323 Achaete-scute complex homologue 2 accelerates the development of Sjgren's syndrome-like disease in the NOD/ShiLtJ mouse.Immunol Lett. 2017 Oct;190:26-33. doi: 10.1016/j.imlet.2017.07.010. Epub 2017 Jul 17.
324 High expression of active ATF6 aggravates endoplasmic reticulum stressinduced vascular endothelial cell apoptosis through the mitochondrial apoptotic pathway.Mol Med Rep. 2018 May;17(5):6483-6489. doi: 10.3892/mmr.2018.8658. Epub 2018 Mar 1.
325 Quercetin induced apoptosis of human oral cancer SAS cells through mitochondria and endoplasmic reticulum mediated signaling pathways.Oncol Lett. 2018 Jun;15(6):9663-9672. doi: 10.3892/ol.2018.8584. Epub 2018 Apr 26.
326 Dynein light chain regulates adaptive and innate B cell development by distinctive genetic mechanisms.PLoS Genet. 2017 Sep 18;13(9):e1007010. doi: 10.1371/journal.pgen.1007010. eCollection 2017 Sep.
327 Comparative analysis of testis transcriptomes associated with male infertility in triploid cyprinid fish.Reprod Fertil Dev. 2019 Jan;31(2):248-260. doi: 10.1071/RD18034.
328 Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma.Int J Hematol. 2020 Jan;111(1):75-83. doi: 10.1007/s12185-019-02766-z. Epub 2019 Nov 4.
329 Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.Cancer Sci. 2017 May;108(5):1071-1079. doi: 10.1111/cas.13213. Epub 2017 Apr 24.
330 MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-B signaling pathway activation.Oncol Lett. 2018 Apr;15(4):4775-4780. doi: 10.3892/ol.2018.7914. Epub 2018 Jan 31.
331 Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation.J Exp Med. 2018 May 7;215(5):1449-1462. doi: 10.1084/jem.20171127. Epub 2018 Mar 7.
332 Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions.J Allergy Clin Immunol. 2014 Apr;133(4):1065-74. doi: 10.1016/j.jaci.2013.09.019. Epub 2013 Nov 1.
333 Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in nonalcoholic fatty liver disease.Mol Med Rep. 2019 Apr;19(4):2649-2659. doi: 10.3892/mmr.2019.9931. Epub 2019 Feb 5.
334 BCL-3 promotes a cancer stem cell phenotype by enhancing -catenin signalling in colorectal tumour cells.Dis Model Mech. 2019 Mar 4;12(3):dmm037697. doi: 10.1242/dmm.037697.
335 Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.DNA Cell Biol. 2019 Apr;38(4):341-351. doi: 10.1089/dna.2018.4396. Epub 2019 Mar 6.
336 Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication.Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26602. Epub 2017 Apr 25.
337 Bex1 attenuates neuronal apoptosis in rat intracerebral hemorrhage model.Pathol Res Pract. 2018 Apr;214(4):527-535. doi: 10.1016/j.prp.2018.02.012. Epub 2018 Feb 21.
338 [Pt(O,O'-acac)(-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells.Biomolecules. 2019 Mar 6;9(3):92. doi: 10.3390/biom9030092.
339 circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.Cell Cycle. 2019 May;18(9):976-989. doi: 10.1080/15384101.2019.1601477. Epub 2019 Apr 16.
340 Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.Cell Rep. 2016 Aug 23;16(8):2061-2067. doi: 10.1016/j.celrep.2016.07.053. Epub 2016 Aug 11.
341 Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.Int J Mol Sci. 2016 Aug 22;17(8):1373. doi: 10.3390/ijms17081373.
342 Identification of IL-40, a Novel B Cell-Associated Cytokine.J Immunol. 2017 Nov 1;199(9):3326-3335. doi: 10.4049/jimmunol.1700534. Epub 2017 Oct 4.
343 Defibrotide Stimulates Angiogenesis and Protects Endothelial Cells from Calcineurin Inhibitor-Induced Apoptosis via Upregulation of AKT/Bcl-xL.Thromb Haemost. 2018 Jan;118(1):161-173. doi: 10.1160/TH17-04-0275. Epub 2018 Jan 5.
344 Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.Oncol Lett. 2019 Feb;17(2):2047-2056. doi: 10.3892/ol.2018.9845. Epub 2018 Dec 18.
345 High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation.Scand J Immunol. 1995 Dec;42(6):581-90. doi: 10.1111/j.1365-3083.1995.tb03700.x.
346 Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.J Allergy Clin Immunol. 2015 Nov;136(5):1139-49. doi: 10.1016/j.jaci.2015.06.031. Epub 2015 Aug 12.
347 Refining the dermatological spectrum in primary immunodeficiency: mucosa-associated lymphoid tissue lymphoma translocation protein 1 deficiency mimicking Netherton/Omenn syndromes.Br J Dermatol. 2020 Jan;182(1):202-207. doi: 10.1111/bjd.18091. Epub 2019 Jul 21.
348 Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.J Cell Mol Med. 2017 Jun;21(6):1182-1192. doi: 10.1111/jcmm.13050. Epub 2017 Feb 3.
349 Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin-4 Deletion Against Ischemia/Reperfusion Injury.J Am Heart Assoc. 2019 Aug 6;8(15):e012047. doi: 10.1161/JAHA.119.012047. Epub 2019 Jul 31.
350 Breviscapine ameliorates CCl4induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation.Int J Mol Med. 2018 Aug;42(2):755-768. doi: 10.3892/ijmm.2018.3651. Epub 2018 May 2.
351 Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.Hum Pathol. 2008 Jun;39(6):885-94. doi: 10.1016/j.humpath.2007.10.014. Epub 2008 Apr 8.
352 CD81 as target for B cell lymphomas.J Exp Med. 2019 Jul 1;216(7):1469-1470. doi: 10.1084/jem.20190733. Epub 2019 Jun 6.
353 Effect of charcoal:dextran stripped fetal bovine serum on in vitro development of bovine embryos.Reprod Biol. 2017 Dec;17(4):312-319. doi: 10.1016/j.repbio.2017.09.002. Epub 2017 Sep 18.
354 Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells.Inflammation. 2017 Oct;40(5):1576-1588. doi: 10.1007/s10753-017-0598-1.
355 CHSY1 promoted proliferation and suppressed apoptosis in colorectal cancer through regulation of the NFB and/or caspase-3/7 signaling pathway.Oncol Lett. 2018 Nov;16(5):6140-6146. doi: 10.3892/ol.2018.9385. Epub 2018 Sep 3.
356 Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.Am J Pathol. 1988 Jul;132(1):1-5.
357 Vaccinia virus Western Reserve induces rapid surface expression of a host molecule detected by the antibody 4C7 that is distinct from CLEC2D.Microbiol Immunol. 2016 Nov;60(11):754-769. doi: 10.1111/1348-0421.12451.
358 The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.Int J Mol Sci. 2017 Jun 1;18(6):1175. doi: 10.3390/ijms18061175.
359 ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.Blood. 2003 Oct 1;102(7):2638-41. doi: 10.1182/blood-2003-04-1050. Epub 2003 May 15.
360 MicroRNA-203-mediated posttranscriptional deregulation of CPEB4 contributes to colorectal cancer progression.Biochem Biophys Res Commun. 2015 Oct 16;466(2):206-13. doi: 10.1016/j.bbrc.2015.09.008. Epub 2015 Sep 8.
361 Emerging therapies for acute myeloid leukemia.J Hematol Oncol. 2017 Apr 18;10(1):93. doi: 10.1186/s13045-017-0463-6.
362 CTBP1 Confers Protection for Hippocampal and Cortical Neurons in Rat Models of Alzheimer's Disease.Neuroimmunomodulation. 2019;26(3):139-152. doi: 10.1159/000500942. Epub 2019 Jul 24.
363 CTHRC1 mediates IL?induced apoptosis in chondrocytes via JNK1/2 signaling.Int J Mol Med. 2018 Apr;41(4):2270-2278. doi: 10.3892/ijmm.2018.3403. Epub 2018 Jan 18.
364 Testicular Injury Attenuated by Rapamycin Through Induction of Autophagy and Inhibition of Endoplasmic Reticulum Stress in Streptozotocin- Induced Diabetic Rats.Endocr Metab Immune Disord Drug Targets. 2019;19(5):665-675. doi: 10.2174/1871530319666190102112844.
365 Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.Oncogene. 1994 Oct;9(10):3049-55.
366 Dynein axonemal intermediate chain 2 plays a role in gametogenesis by activation of Stat3.J Cell Mol Med. 2019 Jan;23(1):417-425. doi: 10.1111/jcmm.13945. Epub 2018 Nov 1.
367 Pipoxolan Exhibits Antitumor Activity Toward Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-mediated Apoptosis.Anticancer Res. 2017 Nov;37(11):6391-6400. doi: 10.21873/anticanres.12092.
368 DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma.Biochem Biophys Res Commun. 2010 Apr 23;395(1):111-5. doi: 10.1016/j.bbrc.2010.03.148. Epub 2010 Mar 27.
369 Adiponectin/AdiopR1 signal inactivation contributes to impaired angiogenesis in mice of advanced age.Int J Cardiol. 2018 Sep 15;267:150-155. doi: 10.1016/j.ijcard.2018.05.089. Epub 2018 May 24.
370 Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.J Cell Mol Med. 2017 Jun;21(6):1117-1127. doi: 10.1111/jcmm.13043. Epub 2016 Dec 13.
371 Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Prostate. 2010 Oct 1;70(14):1575-85. doi: 10.1002/pros.21193.
372 Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.Blood. 2014 Dec 11;124(25):3758-67. doi: 10.1182/blood-2014-07-589689. Epub 2014 Oct 15.
373 Fisetin Induces Apoptosis of HSC3 Human Oral Cancer Cells Through Endoplasmic Reticulum Stress and Dysfunction of Mitochondria-mediated Signaling Pathways.In Vivo. 2017 Nov-Dec;31(6):1103-1114. doi: 10.21873/invivo.11176.
374 Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.Mol Hum Reprod. 2018 Feb 1;24(2):94-109. doi: 10.1093/molehr/gax067.
375 Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.PLoS One. 2011;6(7):e22167. doi: 10.1371/journal.pone.0022167. Epub 2011 Jul 25.
376 LFG-500, a newly synthesized flavonoid, induces apoptosis in human ovarian carcinoma SKOV3 cells with involvement of the reactive oxygen species-mitochondria pathway.Exp Ther Med. 2017 Jun;13(6):2819-2827. doi: 10.3892/etm.2017.4343. Epub 2017 Apr 18.
377 PI3K activates E2F1 synthesis in response to mRNA translation stress.Nat Commun. 2017 Dec 13;8(1):2103. doi: 10.1038/s41467-017-02282-w.
378 Expression of far upstream element binding protein1 in Bcell nonHodgkin lymphoma is correlated with tumor growth and celladhesion mediated drug resistance.Mol Med Rep. 2016 Oct;14(4):3759-68. doi: 10.3892/mmr.2016.5718. Epub 2016 Sep 6.
379 Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.Hum Pathol. 2017 Jan;59:70-79. doi: 10.1016/j.humpath.2016.09.011. Epub 2016 Sep 22.
380 An unusual Fc receptor-related protein expressed in human centroblasts.Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3776-81. doi: 10.1073/pnas.022042699. Epub 2002 Mar 12.
381 Inhibitory effects of FKBP14 on human cervical cancer cells.Mol Med Rep. 2017 Oct;16(4):4265-4272. doi: 10.3892/mmr.2017.7043. Epub 2017 Jul 21.
382 Overexpression of FOXO4 induces apoptosis of clear-cell renal carcinoma cells through downregulation of Bim.Mol Med Rep. 2016 Mar;13(3):2229-34. doi: 10.3892/mmr.2016.4789. Epub 2016 Jan 15.
383 Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma.J Hematol Oncol. 2017 Jun 12;10(1):117. doi: 10.1186/s13045-017-0487-y.
384 Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.FASEB J. 2017 Dec;31(12):5530-5542. doi: 10.1096/fj.201700120RR. Epub 2017 Aug 21.
385 Expanded teased nerve fibre pathological conditions in disease association.J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):138-140. doi: 10.1136/jnnp-2018-319077. Epub 2018 Nov 1.
386 Epigenetic Upregulation of Chicken MicroRNA-16-5p Expression in DF-1 Cells following Infection with Infectious Bursal Disease Virus (IBDV) Enhances IBDV-Induced Apoptosis and Viral Replication.J Virol. 2020 Jan 6;94(2):e01724-19. doi: 10.1128/JVI.01724-19. Print 2020 Jan 6.
387 Silymarin amplifies apoptosis in ectopic endometrial tissue in rats with endometriosis; implication on growth factor GDNF, ERK1/2 and Bcl-6b expression.Acta Histochem. 2018 Nov;120(8):757-767. doi: 10.1016/j.acthis.2018.08.003. Epub 2018 Sep 5.
388 Deregulated NKL Homeobox Genes in B-Cell Lymphoma.Cancers (Basel). 2019 Nov 26;11(12):1874. doi: 10.3390/cancers11121874.
389 Lycium barbarum polysaccharide enhances development of previously-cryopreserved murine two-cell embryos via restoration of mitochondrial function and down-regulated generation of reactive oxygen species.J Reprod Dev. 2019 Apr 12;65(2):163-170. doi: 10.1262/jrd.2018-104. Epub 2019 Jan 31.
390 eRF3b-37 inhibits the TGF-1-induced activation of hepatic stellate cells by regulating cell proliferation, G0/G1 arrest, apoptosis and migration.Int J Mol Med. 2018 Dec;42(6):3602-3612. doi: 10.3892/ijmm.2018.3900. Epub 2018 Sep 26.
391 Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1499-1504. doi: 10.1073/pnas.1721967115. Epub 2018 Jan 30.
392 Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.Cancer Res. 2002 Nov 1;62(21):6224-30.
393 HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.Leuk Res. 2016 Jun;45:90-100. doi: 10.1016/j.leukres.2016.04.007. Epub 2016 Apr 11.
394 Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice.Blood. 2013 Mar 28;121(13):2553-62. doi: 10.1182/blood-2012-06-434530. Epub 2013 Jan 29.
395 Chromatin remodeling factor lymphoid-specific helicase links with Epstein-Barr virus associated the follicular germinal center B cell lymphomas.J Cancer Res Ther. 2019;15(2):350-357. doi: 10.4103/jcrt.JCRT_243_18.
396 Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.Cancer Res. 2007 Sep 15;67(18):8923-31. doi: 10.1158/0008-5472.CAN-07-2153.
397 The long noncoding RNA ASNR regulates degradation of Bcl-2 mRNA through its interaction with AUF1.Sci Rep. 2016 Aug 31;6:32189. doi: 10.1038/srep32189.
398 Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas.J Natl Cancer Inst. 2020 Jan 1;112(1):95-106. doi: 10.1093/jnci/djz078.
399 hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma.EMBO J. 2019 Feb 1;38(3):e99128. doi: 10.15252/embj.201899128. Epub 2018 Dec 7.
400 Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.Int J Oncol. 2018 Jun;52(6):2093-2100. doi: 10.3892/ijo.2018.4352. Epub 2018 Apr 2.
401 Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.Mol Cancer Ther. 2019 Dec;18(12):2270-2282. doi: 10.1158/1535-7163.MCT-19-0385. Epub 2019 Sep 4.
402 HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.Blood. 2015 Mar 12;125(11):1768-71. doi: 10.1182/blood-2014-07-590034. Epub 2015 Jan 8.
403 Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.J Biol Chem. 2011 Oct 28;286(43):37368-78. doi: 10.1074/jbc.M111.255125. Epub 2011 Sep 9.
404 Ibrutinib and Venetoclax for First-Line Treatment of CLL.N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574.
405 Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway.Oncol Lett. 2018 Aug;16(2):1634-1640. doi: 10.3892/ol.2018.8849. Epub 2018 May 31.
406 Potential Prognostic Molecular Signatures in a Preclinical Model of Melanoma.Anticancer Res. 2017 Jan;37(1):143-148. doi: 10.21873/anticanres.11299.
407 IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development.Cancer Immunol Res. 2019 Jun;7(6):874-885. doi: 10.1158/2326-6066.CIR-18-0698. Epub 2019 Apr 24.
408 IL4I1: an inhibitor of the CD8?antitumor T-cell response in vivo.Eur J Immunol. 2011 Jun;41(6):1629-38. doi: 10.1002/eji.201041119. Epub 2011 May 13.
409 IQ Motif Containing GTPase-Activating Protein 3 (IQGAP3) Inhibits Kaempferol-Induced Apoptosis in Breast Cancer Cells by Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) Signaling Activation.Med Sci Monit. 2019 Oct 12;25:7666-7674. doi: 10.12659/MSM.915642.
410 The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.Biochim Biophys Acta. 2015 May;1852(5):742-8. doi: 10.1016/j.bbadis.2014.12.018. Epub 2014 Dec 31.
411 Acalabrutinib for adults with mantle cell lymphoma.Expert Rev Clin Pharmacol. 2019 Mar;12(3):179-187. doi: 10.1080/17512433.2019.1568868. Epub 2019 Jan 26.
412 The elevated activation of NFB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.Clin Oral Investig. 2017 Dec;21(9):2721-2731. doi: 10.1007/s00784-017-2074-6. Epub 2017 Feb 23.
413 Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.Am J Clin Pathol. 2008 Dec;130(6):957-62. doi: 10.1309/AJCP12HIRWSRQLAN.
414 Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14.Sci Rep. 2018 Nov 1;8(1):16152. doi: 10.1038/s41598-018-34603-4.
415 Downregulated microRNA-92a-3p inhibits apoptosis and promotes proliferation of pancreatic acinar cells in acute pancreatitis by enhancing KLF2 expression.J Cell Biochem. 2020 Aug;121(8-9):3739-3751. doi: 10.1002/jcb.29517. Epub 2019 Nov 12.
416 The HDAC6-selective inhibitor is effective against non-Hodgkin lymphoma and synergizes with ibrutinib in follicular lymphoma.Mol Carcinog. 2019 Jun;58(6):944-956. doi: 10.1002/mc.22983. Epub 2019 Feb 27.
417 miR-103/107 promote ER stress-mediated apoptosis via targeting the Wnt3a/-catenin/ATF6 pathway in preadipocytes.J Lipid Res. 2018 May;59(5):843-853. doi: 10.1194/jlr.M082602. Epub 2018 Feb 26.
418 Next generation sequencing revealed DNA ligase IV deficiency in a "developmentally normal" patient with massive brain Epstein-Barr virus-positive diffuse large B-cell lymphoma.Clin Immunol. 2016 Feb;163:108-10. doi: 10.1016/j.clim.2016.01.002. Epub 2016 Jan 13.
419 Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-likevia LIN9.Oncol Lett. 2017 Oct;14(4):4461-4466. doi: 10.3892/ol.2017.6750. Epub 2017 Aug 14.
420 LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.PLoS One. 2017 Apr 4;12(4):e0175122. doi: 10.1371/journal.pone.0175122. eCollection 2017.
421 Investigation of the association between miR?81b, Bcl? and LRIG1 in oral verrucous carcinoma.Mol Med Rep. 2016 Oct;14(4):2991-6. doi: 10.3892/mmr.2016.5608. Epub 2016 Aug 9.
422 NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo.Apoptosis. 2019 Feb;24(1-2):83-94. doi: 10.1007/s10495-018-1498-z.
423 Methylation of p16INK4A and mitotic arrest defective protein 2 (MAD2) genes in gastric marginal-zone B-cell lymphomas.Acta Haematol. 2008;120(4):217-24. doi: 10.1159/000195698. Epub 2009 Jan 28.
424 Atrazine hinders PMA-induced neutrophil extracellular traps in carp via the promotion of apoptosis and inhibition of ROS burst, autophagy and glycolysis.Environ Pollut. 2018 Dec;243(Pt A):282-291. doi: 10.1016/j.envpol.2018.08.070. Epub 2018 Aug 22.
425 Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2).Support Care Cancer. 2020 Feb;28(2):571-579. doi: 10.1007/s00520-019-04802-4. Epub 2019 May 15.
426 Expression of hsa-MIR-204, RUNX2, PPAR, and BCL2 in Bone Marrow Derived Mesenchymal Stem Cells from Multiple Myeloma Patients and Normal Individuals.Cell J. 2017 Spring;19(Suppl 1):27-36. doi: 10.22074/cellj.2017.4480. Epub 2017 May 17.
427 Expression of minichromosome maintenance 8 in chronic myelogenous leukemia.Int J Clin Exp Pathol. 2015 Nov 1;8(11):14180-8. eCollection 2015.
428 BRCT-domain protein BRIT1 influences class switch recombination.Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8354-8359. doi: 10.1073/pnas.1708211114. Epub 2017 Jul 19.
429 Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015.
430 Arsenic-induced cardiotoxicity correlates with mitochondrial damage and trace elements imbalance in broiler chickens.Poult Sci. 2019 Feb 1;98(2):734-744. doi: 10.3382/ps/pey469.
431 Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma.Appl Immunohistochem Mol Morphol. 2020 May/Jun;28(5):384-388. doi: 10.1097/PAI.0000000000000738.
432 Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.Anticancer Res. 2019 Dec;39(12):6635-6643. doi: 10.21873/anticanres.13878.
433 MSX2 and BCL2 expressions in the development of anorectal malformations in ethylenethiourea-induced rat embryos.Exp Mol Pathol. 2018 Dec;105(3):311-321. doi: 10.1016/j.yexmp.2018.09.005. Epub 2018 Sep 28.
434 Methylenetetrahydrofolate Dehydrogenase 1 Silencing Expedites the Apoptosis of Non-Small Cell Lung Cancer Cells via Modulating DNA Methylation.Med Sci Monit. 2018 Oct 21;24:7499-7507. doi: 10.12659/MSM.910265.
435 Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.Biochem Biophys Res Commun. 2017 Jan 8;482(2):310-316. doi: 10.1016/j.bbrc.2016.11.060. Epub 2016 Nov 14.
436 Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma.Int J Oncol. 2016 Apr;48(4):1561-70. doi: 10.3892/ijo.2016.3393. Epub 2016 Feb 17.
437 Effects of nuclear respiratory factor? on apoptosis and mitochondrial dysfunction induced by cobalt chloride in H9C2 cells.Mol Med Rep. 2019 Mar;19(3):2153-2163. doi: 10.3892/mmr.2019.9839. Epub 2019 Jan 10.
438 Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.Blood. 2016 Dec 8;128(23):2666-2670. doi: 10.1182/blood-2016-03-704528. Epub 2016 Sep 26.
439 The use of flow cytometry in the diagnosis and biological characterization of the non-Hodgkin's lymphomas.Ann N Y Acad Sci. 1986;468:171-7. doi: 10.1111/j.1749-6632.1986.tb42038.x.
440 Bacillus amyloliquefaciens Ameliorates H(2)O(2)-Induced Oxidative Damage by Regulating Transporters, Tight Junctions, and Apoptosis Gene Expression in Cell Line IPEC-1.Probiotics Antimicrob Proteins. 2020 Jun;12(2):649-656. doi: 10.1007/s12602-019-09538-5.
441 Aneuploidy-inducing gene knockdowns overlap with cancer mutations and identify Orp3 as a B-cell lymphoma suppressor.Oncogene. 2020 Feb;39(7):1445-1465. doi: 10.1038/s41388-019-1073-2. Epub 2019 Oct 28.
442 DNA methylation profiling implicates exposure to PCBs in the pathogenesis of B-cell chronic lymphocytic leukemia.Environ Int. 2019 May;126:24-36. doi: 10.1016/j.envint.2019.01.068. Epub 2019 Feb 15.
443 PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.BMC Cancer. 2018 May 2;18(1):499. doi: 10.1186/s12885-018-4391-9.
444 MicroRNA?06 contributes to the progression of steroidinduced avascular necrosis of the femoral head by inducing osteoblast apoptosis by suppressing programmed cell death 4.Mol Med Rep. 2018 Jan;17(1):801-808. doi: 10.3892/mmr.2017.7963. Epub 2017 Nov 3.
445 The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes.Front Immunol. 2019 Jun 20;10:1382. doi: 10.3389/fimmu.2019.01382. eCollection 2019.
446 Activation of Casein Kinase II by Gallic Acid Induces BIK-BAX/BAK-Mediated ER Ca(++)-ROS-Dependent Apoptosis of Human Oral Cancer Cells.Front Physiol. 2017 Sep 29;8:761. doi: 10.3389/fphys.2017.00761. eCollection 2017.
447 PIAS1 Promotes Lymphomagenesis through MYC Upregulation.Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26.
448 A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).Front Immunol. 2019 Apr 16;10:777. doi: 10.3389/fimmu.2019.00777. eCollection 2019.
449 Nonsense-mediated mRNA decay: The challenge of telling right from wrong in a complex transcriptome.Wiley Interdiscip Rev RNA. 2019 Nov;10(6):e1548. doi: 10.1002/wrna.1548. Epub 2019 May 26.
450 Lipid storage droplet protein 5 reduces sodium palmitateinduced lipotoxicity in human normal liver cells by regulating lipid metabolismrelated factors.Mol Med Rep. 2019 Aug;20(2):879-886. doi: 10.3892/mmr.2019.10360. Epub 2019 Jun 6.
451 Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.Oncotarget. 2017 Sep 27;8(59):99722-99739. doi: 10.18632/oncotarget.21283. eCollection 2017 Nov 21.
452 Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background.Genome Res. 2015 Nov;25(11):1634-45. doi: 10.1101/gr.194449.115. Epub 2015 Sep 16.
453 Sodium azide induces mitochondriamediated apoptosis in PC12 cells through Pgc?associated signaling pathway.Mol Med Rep. 2019 Mar;19(3):2211-2219. doi: 10.3892/mmr.2019.9853. Epub 2019 Jan 14.
454 The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas.Oncotarget. 2016 Nov 8;7(45):72415-72430. doi: 10.18632/oncotarget.11719.
455 Immune thrombocytopenia induces autophagy and suppresses apoptosis in megakaryocytes.Mol Med Rep. 2018 Oct;18(4):4016-4022. doi: 10.3892/mmr.2018.9373. Epub 2018 Aug 9.
456 Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.Oncol Lett. 2018 Jan;15(1):731-740. doi: 10.3892/ol.2017.7400. Epub 2017 Nov 14.
457 Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.Oncotarget. 2017 Apr 25;8(17):27915-27928. doi: 10.18632/oncotarget.15843.
458 Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus.Clin Pharmacokinet. 2020 Mar;59(3):335-347. doi: 10.1007/s40262-019-00818-5.
459 The Pivotal Role of Long Noncoding RNA RAB5IF in the Proliferation of Hepatocellular Carcinoma Via LGR5 Mediated -Catenin and c-Myc Signaling.Biomolecules. 2019 Nov 8;9(11):718. doi: 10.3390/biom9110718.
460 Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma. PLoS One. 2013 Nov 6;8(11):e79863. doi: 10.1371/journal.pone.0079863. eCollection 2013.
461 Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.J Clin Immunol. 2018 Aug;38(6):699-710. doi: 10.1007/s10875-018-0533-8. Epub 2018 Jul 20.
462 Theaflavins attenuate ethanolinduced oxidative stress and cell apoptosis in gastric mucosa epithelial cells via downregulation of the mitogenactivated protein kinase pathway.Mol Med Rep. 2018 Oct;18(4):3791-3799. doi: 10.3892/mmr.2018.9352. Epub 2018 Aug 3.
463 REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.PLoS One. 2015 Mar 17;10(3):e0120334. doi: 10.1371/journal.pone.0120334. eCollection 2015.
464 miRNA?04 inhibits p53dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formation.Mol Med Rep. 2017 Sep;16(3):2570-2578. doi: 10.3892/mmr.2017.6873. Epub 2017 Jun 28.
465 PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.Nat Commun. 2019 Mar 29;10(1):1415. doi: 10.1038/s41467-019-09180-3.
466 Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.Leukemia. 2007 Aug;21(8):1846-7. doi: 10.1038/sj.leu.2404717. Epub 2007 Apr 19.
467 Genome-derived cytosolic DNA contributes to type I interferon expression and immunogenicity of B-cell lymphoma cells.Cytokine. 2015 Dec;76(2):581-582. doi: 10.1016/j.cyto.2015.05.024. Epub 2015 Jun 9.
468 The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.Leukemia. 2019 Feb;33(2):319-332. doi: 10.1038/s41375-018-0176-z. Epub 2018 Jun 21.
469 Therapeutic Efficacy of 4-1BB Costimulation Is Abrogated by PD-1 Blockade in a Model of Spontaneous B-cell Lymphoma.Cancer Immunol Res. 2017 Mar;5(3):191-197. doi: 10.1158/2326-6066.CIR-16-0249. Epub 2017 Jan 23.
470 AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway.Oncol Lett. 2017 Jul;14(1):981-986. doi: 10.3892/ol.2017.6214. Epub 2017 May 19.
471 Nox4 is involved in high glucose-induced apoptosis in renal tubular epithelial cells via Notch pathway.Mol Med Rep. 2017 Jun;15(6):4319-4325. doi: 10.3892/mmr.2017.6516. Epub 2017 Apr 26.
472 Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics.FEBS J. 2009 Nov;276(21):6050-62. doi: 10.1111/j.1742-4658.2009.07329.x. Epub 2009 Sep 29.
473 Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells.FEBS Open Bio. 2018 Apr 10;8(5):743-750. doi: 10.1002/2211-5463.12412. eCollection 2018 May.
474 Opposite response to hypoxia by breast cancer cells between cell proliferation and cell migration: A clue from microRNA expression profile.Oncol Lett. 2018 Mar;15(3):2771-2780. doi: 10.3892/ol.2017.7636. Epub 2017 Dec 19.
475 The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.Haematologica. 2013 May;98(5):739-43. doi: 10.3324/haematol.2012.066977. Epub 2012 Oct 12.
476 Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.J Pediatr Hematol Oncol. 2017 May;39(4):e203-e206. doi: 10.1097/MPH.0000000000000815.
477 Overexpression of Shrm4 promotes proliferation and differentiation of neural stem cells through activation of GABA signaling pathway.Mol Cell Biochem. 2020 Jan;463(1-2):115-126. doi: 10.1007/s11010-019-03634-4. Epub 2019 Oct 25.
478 SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.J Biol Chem. 2014 Feb 14;289(7):4135-44. doi: 10.1074/jbc.M113.525949. Epub 2013 Dec 24.
479 Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. Lancet Oncol. 2018 May;19(5):649-659. doi: 10.1016/S1470-2045(18)30145-1. Epub 2018 Apr 9.
480 Blue light emitting diode induces apoptosis in lymphoid cells by stimulating autophagy.Int J Biochem Cell Biol. 2016 Jan;70:13-22. doi: 10.1016/j.biocel.2015.11.004. Epub 2015 Nov 10.
481 Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.Am J Surg Pathol. 2020 Feb;44(2):232-240. doi: 10.1097/PAS.0000000000001390.
482 Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis.Eur J Cancer Prev. 2020 Mar;29(2):165-173. doi: 10.1097/CEJ.0000000000000535.
483 Stat5-dependent cardioprotection in late remote ischaemia preconditioning.Cardiovasc Res. 2018 Apr 1;114(5):679-689. doi: 10.1093/cvr/cvy014.
484 Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination.Cancers (Basel). 2018 Oct 26;10(11):402. doi: 10.3390/cancers10110402.
485 Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.Oncotarget. 2016 Jan 19;7(3):2391-400. doi: 10.18632/oncotarget.6165.
486 Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling.Drug Dev Res. 2019 Nov;80(7):933-947. doi: 10.1002/ddr.21573. Epub 2019 Jul 25.
487 Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis.J Clin Endocrinol Metab. 2016 Apr;101(4):1552-61. doi: 10.1210/jc.2016-1120. Epub 2016 Mar 15.
488 TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.FEBS J. 2019 Sep;286(18):3566-3581. doi: 10.1111/febs.14934. Epub 2019 Jun 3.
489 Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment.Biochem Biophys Res Commun. 2010 May 28;396(2):329-34. doi: 10.1016/j.bbrc.2010.04.092. Epub 2010 Apr 18.
490 Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice.Oncogene. 2006 Apr 27;25(18):2575-87. doi: 10.1038/sj.onc.1209285.
491 TM4SF1 inhibits apoptosis and promotes proliferation, migration and invasion in human gastric cancer cells.Oncol Lett. 2018 Nov;16(5):6081-6088. doi: 10.3892/ol.2018.9411. Epub 2018 Sep 6.
492 A developed antibody-drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line.Artif Cells Nanomed Biotechnol. 2018;46(sup2):1-8. doi: 10.1080/21691401.2018.1449119. Epub 2018 Mar 9.
493 Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodies.J Immunother. 2010 Jun;33(5):500-9. doi: 10.1097/CJI.0b013e3181d75c20.
494 Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.J Breast Cancer. 2019 Jun;22(2):172-184. doi: 10.4048/jbc.2019.22.e21.
495 Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.Exp Ther Med. 2019 Sep;18(3):1653-1660. doi: 10.3892/etm.2019.7718. Epub 2019 Jul 1.
496 The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.Blood Adv. 2017 Dec 18;1(27):2712-2723. doi: 10.1182/bloodadvances.2017009670. eCollection 2017 Dec 26.
497 Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.Tumour Biol. 2015 Sep;36(9):6901-8. doi: 10.1007/s13277-015-3377-3. Epub 2015 Apr 8.
498 Transient Receptor Potential Vanilloid 5 Mediates Ca2+ Influx and Inhibits Chondrocyte Autophagy in a Rat Osteoarthritis Model.Cell Physiol Biochem. 2017;42(1):319-332. doi: 10.1159/000477387. Epub 2017 May 25.
499 TSPAN33 is a novel marker of activated and malignant B cells.Clin Immunol. 2013 Dec;149(3):388-99. doi: 10.1016/j.clim.2013.08.005. Epub 2013 Aug 15.
500 Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines.Tumori. 2018 Oct;104(5):394-400. doi: 10.5301/tj.5000606. Epub 2018 May 8.
501 MLL-AF4 gene rearrangement in a child with Epstein-Barr virus-related posttransplant B-cell lymphoma.J Pediatr Hematol Oncol. 2003 Sep;25(9):740-2. doi: 10.1097/00043426-200309000-00013.
502 Effect of shRNA targeting mouse CD99L2 gene in a murine B cell lymphoma in vitro and in vivo.Oncol Rep. 2013 Apr;29(4):1405-14. doi: 10.3892/or.2013.2244. Epub 2013 Jan 18.
503 CDK5RAP1 targeting NF-B signaling pathway in human malignant melanoma A375 cell apoptosis.Oncol Lett. 2018 Apr;15(4):4767-4774. doi: 10.3892/ol.2018.7920. Epub 2018 Feb 1.
504 DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.Leukemia. 2008 May;22(5):1035-43. doi: 10.1038/leu.2008.18. Epub 2008 Feb 21.
505 Death associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies.Apoptosis. 2002 Jun;7(3):261-70. doi: 10.1023/a:1015364104672.
506 New fusion transcripts identified in normal karyotype acute myeloid leukemia.PLoS One. 2012;7(12):e51203. doi: 10.1371/journal.pone.0051203. Epub 2012 Dec 12.
507 Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.J Pathol. 2006 Sep;210(1):10-8. doi: 10.1002/path.2023.
508 Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.Haematologica. 2002 Jan;87(1):33-43.
509 Screening for biomarkers of spermatogonia within the human testis: a whole genome approach.Hum Reprod. 2010 May;25(5):1104-12. doi: 10.1093/humrep/deq053. Epub 2010 Mar 5.
510 Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.Neoplasia. 2005 Jan;7(1):7-16. doi: 10.1593/neo.04535.
511 Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.Blood. 2002 Jun 15;99(12):4554-61. doi: 10.1182/blood.v99.12.4554.
512 Molecular mapping of the chromosome 11 breakpoint of t(11;17)(q13;q21) in a t(11;14)(q13;q32)-positive B non-Hodgkin's lymphoma.Genes Chromosomes Cancer. 1993 Dec;8(4):224-9. doi: 10.1002/gcc.2870080404.
513 WNT and FGF gene clusters (review).Int J Oncol. 2002 Dec;21(6):1269-73.
514 Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-B regulation.EMBO J. 2012 Oct 3;31(19):3856-70. doi: 10.1038/emboj.2012.241. Epub 2012 Aug 28.
515 Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.Am J Pathol. 2001 Aug;159(2):425-9. doi: 10.1016/S0002-9440(10)61713-0.
516 Current targeted therapies in lymphomas.Am J Health Syst Pharm. 2019 Oct 30;76(22):1825-1834. doi: 10.1093/ajhp/zxz202.
517 Recognition DNA sequence of a novel putative transcription factor, BCL6.Biochem Biophys Res Commun. 1994 Oct 14;204(1):366-74. doi: 10.1006/bbrc.1994.2468.
518 B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.J Clin Immunol. 2013 Aug;33(6):1062-6. doi: 10.1007/s10875-013-9907-0. Epub 2013 Jun 26.
519 Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from non-germinal center cells and constitutes a new diagnostic tool for B-cell malignancies.Leukemia. 2007 Jun;21(6):1285-93. doi: 10.1038/sj.leu.2404689. Epub 2007 Apr 12.
520 Indirect stimulation of B-cell proliferation in vitro by T cells, as evidenced by cytogenetic analysis of PHA-stimulated cell cultures of B-cell lymphomas.Cancer Genet Cytogenet. 1984 Apr;11(4):425-8. doi: 10.1016/0165-4608(84)90023-2.
521 Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma.Genes Chromosomes Cancer. 1999 Oct;26(2):97-105.
522 Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.Oncogene. 2007 Oct 18;26(48):6937-47. doi: 10.1038/sj.onc.1210494. Epub 2007 May 7.
523 Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation.Cell Signal. 2009 Dec;21(12):1837-45. doi: 10.1016/j.cellsig.2009.07.019. Epub 2009 Aug 8.
524 The predicted DBL oncogene product defines a distinct class of transforming proteins.Proc Natl Acad Sci U S A. 1988 Apr;85(7):2061-5. doi: 10.1073/pnas.85.7.2061.
525 MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.Oncogene. 2004 Apr 1;23(14):2576-81. doi: 10.1038/sj.onc.1207352.
526 Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types.Proc Natl Acad Sci U S A. 1983 Apr;80(7):1947-50. doi: 10.1073/pnas.80.7.1947.
527 A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.Oncogene. 2010 Jun 3;29(22):3287-96. doi: 10.1038/onc.2010.82. Epub 2010 Mar 22.
528 A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation.Blood. 2000 Aug 1;96(3):1013-20.
529 Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.EMBO J. 1994 Aug 1;13(15):3487-95. doi: 10.1002/j.1460-2075.1994.tb06655.x.
530 Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.PLoS One. 2013;8(2):e56829. doi: 10.1371/journal.pone.0056829. Epub 2013 Feb 25.
531 The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.Oncogene. 2012 Mar 15;31(11):1442-58. doi: 10.1038/onc.2011.331. Epub 2011 Aug 1.
532 The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor.J Immunol. 2000 Sep 1;165(5):2544-55. doi: 10.4049/jimmunol.165.5.2544.
533 Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas.Am J Pathol. 2004 Feb;164(2):533-42. doi: 10.1016/S0002-9440(10)63143-4.
534 Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma.N Engl J Med. 2004 Sep 30;351(14):1419-24. doi: 10.1056/NEJMoa041432.
535 Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.Cancer Biol Ther. 2013 Jul;14(7):679-91. doi: 10.4161/cbt.25091. Epub 2013 May 31.
536 Structure of the human retinoblastoma-related p107 gene and its intragenic deletion in a B-cell lymphoma cell line.Gene. 2000 Jun 13;251(1):37-43. doi: 10.1016/s0378-1119(00)00193-1.
537 Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.Leukemia. 1996 Feb;10(2):351-5.
538 Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types.Genomics. 1998 Jun 1;50(2):170-86. doi: 10.1006/geno.1998.5321.
539 ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.Blood. 2004 Feb 15;103(4):1454-63. doi: 10.1182/blood-2003-06-2081. Epub 2003 Oct 9.
540 Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.Am J Pathol. 2003 Jul;163(1):135-44. doi: 10.1016/S0002-9440(10)63637-1.
541 Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1.Nat Commun. 2013;4:2598. doi: 10.1038/ncomms3598.
542 Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.Haematologica. 2004 Aug;89(8):957-64.
543 STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis.Oncogene. 2012 Oct 4;31(40):4384-96. doi: 10.1038/onc.2011.604. Epub 2012 Jan 9.
544 TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway.Oncogene. 2010 Mar 4;29(9):1362-73. doi: 10.1038/onc.2009.431. Epub 2009 Dec 7.
545 Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.Int J Clin Exp Pathol. 2013;6(4):788-94. Epub 2013 Mar 15.
546 Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.Histopathology. 2008 Apr;52(5):578-84. doi: 10.1111/j.1365-2559.2008.02970.x. Epub 2008 Feb 23.